{"content":"<li class=\"n-box-item date-title\" data-end=\"1544245199\" data-start=\"1544158800\" data-txt=\"Monday, December 23, 2019\">Friday, December  7, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3415455\" data-ts=\"1544223002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPR\" target=\"_blank\">TPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415455-tpr-nnn-and-lyb-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TPR, NNN and LYB among after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/TPR' title='Tapestry, Inc.'>TPR</a> <font color=\"green\">+6.5%</font>. <a href='https://seekingalpha.com/symbol/LAZ' title='Lazard Ltd.'>LAZ</a> <font color=\"green\">+5.4%</font>. <a href='https://seekingalpha.com/symbol/LYB' title='LyondellBasell Industries N.V.'>LYB</a> <font color=\"green\">+5.1%</font>. <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color=\"green\">+4.9%</font>. <a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a> <font color=\"green\">+4.7%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color=\"red\">-2.9%</font>. <a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a> <font color=\"red\">-2.5%</font>. <a href='https://seekingalpha.com/symbol/NNN' title='National Retail Properties, Inc.'>NNN</a> <font color=\"red\">-2.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415455\" data-linked=\"TPR, NNN and LYB among after hour movers\" data-tweet=\"$TPR $TPR $LAZ - TPR, NNN and LYB among after hour movers https://seekingalpha.com/news/3415455-tpr-nnn-and-lyb-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415455-tpr-nnn-and-lyb-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415426\" data-ts=\"1544217064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGNX\" target=\"_blank\">MGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415426-fda-suspends-enrollment-in-clinical-studies-of-macrogenics-mgd009-on-safety-signal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA suspends enrollment in clinical studies of MacroGenics&#39; MGD009 on safety signal</a></h4><ul><li>The FDA has <a href=\"https://seekingalpha.com/pr/17352294-macrogenics-announces-partial-clinical-hold-mgd009-phase-1-studies\" target=\"_blank\">instituted </a>a partial clinical hold on two clinical trials evaluating MacroGenics' (NASDAQ:<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a>) bispecific DART molecule MGD009 due to due potential liver effects, including elevated liver enzymes with or without concurrent elevations in bilirubin. The company says the effects have been uncomplicated and short in duration. It plans to amend the protocols to include additional care to address the events.</li><li>A partial clinical hold means that no new patients may be enrolled but those already in the studies may continue receiving treatment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415426\" data-linked=\"FDA suspends enrollment in clinical studies of MacroGenics&#39; MGD009 on safety signal\" data-tweet=\"$MGNX - FDA suspends enrollment in clinical studies of MacroGenics&#39; MGD009 on safety signal https://seekingalpha.com/news/3415426-fda-suspends-enrollment-in-clinical-studies-of-macrogenics-mgd009-on-safety-signal?source=tweet\" data-url=\"https://seekingalpha.com/news/3415426-fda-suspends-enrollment-in-clinical-studies-of-macrogenics-mgd009-on-safety-signal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415415\" data-ts=\"1544215218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QDEL\" target=\"_blank\">QDEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415415-quidel-loses-bid-to-stop-beckman-from-directly-selling-bnp-assay-shares-down-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quidel loses bid to stop Beckman from directly selling BNP assay; shares down 19%</a></h4><ul><li>Thinly traded Quidel (<a href='https://seekingalpha.com/symbol/QDEL' title='Quidel Corporation'>QDEL</a> <font color=\"red\">-18.7%</font>) is down on modestly higher volume, albeit on turnover of only 299K shares, in response to the <a href=\"https://seekingalpha.com/pr/17352273-quidel-comments-california-court-ruling\" target=\"_blank\">news </a>that Beckman has prevailed in a lawsuit related to the sale of test called B-type natriuretic peptide &#40;BNP&#41;. The company owns exclusive rights to sell the test, called Triage BNP, on Beckman Coulter analyzers but Beckman wants to sell the test directly to its customers.Â The California court intends to enter an order allowing Beckman to do just that.</li><li>Quidel says the litigation is broader that this one issue and it expects to ultimately prevail. The trial remains scheduled for August 30, 2019.</li><li>The situation arose from Abbott's takeout of Alere more than a year ago. The BNP rights were <a href=\"https://www.darkintelligencegroup.com/the-dark-report/laboratory-management/beckman-coulter-sues-quidel-right-sell-bnp-assay/\" target=\"_blank\">in-licensed</a> by BioSite Diagnostics in late 1996. BioSite was subsequently acquired by Alere (then d/b/a Inverness Medical Innovations). In order to satisfy antitrust concerns with the Abbott tie-up, Alere sold its Triage MeterPro and Triage BNP lines to Quidel.</li><li>Quidel's Cardiac Immunoassay sales, which include Triage and Beckman BNP, accounted for 52% ($203.6M/$389.7) of 2018 ytd sales.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314489-quidel-14-percent-beckman-move-sell-bnp-assay-directly\" target=\"_blank\">Quidel down 14% on Beckman move to sell BNP assay directly</a> (Nov. 27, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415415\" data-linked=\"Quidel loses bid to stop Beckman from directly selling BNP assay; shares down 19%\" data-tweet=\"$QDEL - Quidel loses bid to stop Beckman from directly selling BNP assay; shares down 19% https://seekingalpha.com/news/3415415-quidel-loses-bid-to-stop-beckman-from-directly-selling-bnp-assay-shares-down-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3415415-quidel-loses-bid-to-stop-beckman-from-directly-selling-bnp-assay-shares-down-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415414\" data-ts=\"1544214592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415414-airlines-in-broad-selloff-wolfe-research-sees-cloudy-skies-ahead-for-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Airlines in broad selloff; Wolfe Research sees cloudy skies ahead for sector</a></h4><ul><li>Airline stocks are plunging, with the sector on track to suffer its <a href=\"https://www.marketwatch.com/story/airline-stocks-suffer-broad-selloff-as-economic-growth-oil-price-concerns-prompt-sector-downgrade-2018-12-07\" target=\"_blank\">biggest one-day loss since February 2016</a>, slammed by the recent weakness in oil prices and concerns over a slowing economy.</li><li>Wolfe Research <a href=\"https://www.barrons.com/articles/airline-stocks-might-not-be-ready-to-take-off-1544204609\" target=\"_blank\">downgrades the airline sector</a> to Underweight from Overweight, saying that while a recession and lower oil are both \"toxic\" for air carriers, \"we trust airlines to react better to a recession than we trust them not to behave poorly with lower oil prices.\"</li><li>While the airlines have made changes to better position themselves in downturns, the industry\u2019s poor track record looms large, Wolfe's Hunter Keay says, adding that while investors can hope that the next recession will allow carriers to prove they\u2019ve learned lessons, the best place to watch is from the sidelines.</li><li>Among individual names, Keay cuts American Airlines (<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a> <font color=\"red\">-9%</font>), Hawaiian Holdings (<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a> <font color=\"red\">-9.4%</font>) and Spirit Airlines (<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines'>SAVE</a> <font color=\"red\">-8.3%</font>) to Peer Perform from Outperform, and JetBlue (<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a> <font color=\"red\">-5.6%</font>) and WestJet (<a href='https://seekingalpha.com/symbol/WJAFF' title='WestJet Airlines Ltd.'>OTC:WJAFF</a> <font color=\"red\">-3%</font>) to Underperform from Peer Perform.</li><li>But Keay reiterates his Outperform rating on Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color=\"red\">-3.8%</font>) and upgrades Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color=\"red\">-4.1%</font>) to Outperform from Peer Perform; he likes DAL\u2019s variable cost structure and strong balance sheet and margins, and he thinks LUV's track record means the stock is one of the better airlines to invest in during a downturn.</li><li>ETF: <a href='https://seekingalpha.com/symbol/JETS' title='U.S. Global Jets ETF'>JETS</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415414\" data-linked=\"Airlines in broad selloff; Wolfe Research sees cloudy skies ahead for sector\" data-tweet=\"$AAL $AAL $HA - Airlines in broad selloff; Wolfe Research sees cloudy skies ahead for sector https://seekingalpha.com/news/3415414-airlines-in-broad-selloff-wolfe-research-sees-cloudy-skies-ahead-for-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3415414-airlines-in-broad-selloff-wolfe-research-sees-cloudy-skies-ahead-for-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>69&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415406\" data-ts=\"1544212811\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOMO\" target=\"_blank\">DOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415406-technology-top-5-gainers-losers-of-3_00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3.00 PM</a></h4><ul><li><strong>Gainers:Â </strong>Domo (NASDAQ:<a href='https://seekingalpha.com/symbol/DOMO' title='Domo, Inc.'>DOMO</a>) <font color=\"green\">+27%</font>.Â Uxin Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a>) <font color=\"green\">+26%</font>. Qualstar Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/QBAK' title='Qualstar Corporation'>QBAK</a>) <font color=\"green\">+21%</font>. Innodata (NASDAQ:<a href='https://seekingalpha.com/symbol/INOD' title='Innodata Inc.'>INOD</a>) <font color=\"green\">+15%</font>. Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers:Â </strong>SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"red\">-20%</font>. Coupa Software Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Inc'>COUP</a>) <font color=\"red\">-12%</font>. Sphere 3D (NASDAQ:<a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a>) <font color=\"red\">-10%</font>. Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a>) <font color=\"red\">-10%</font>. Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415406\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3.00 PM\" data-tweet=\"$DOMO $DOMO $UXIN - Technology - Top 5 Gainers / Losers as of 3.00 PM https://seekingalpha.com/news/3415406-technology-top-5-gainers-losers-of-3_00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3415406-technology-top-5-gainers-losers-of-3_00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415398\" data-ts=\"1544211535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BASFY\" target=\"_blank\">BASFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415398-basfminus-4-after-cutting-2018-profit-outlook-now-seen-falling-15minus-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BASF -4% after cutting 2018 profit outlook, now seen falling 15%-20%</a></h4><ul><li>BASF (<a href='https://seekingalpha.com/symbol/BASFY' title='BASF SE ADR'>OTCQX:BASFY</a> <font color=\"red\">-4.3%</font>) turns sharply lower after <a href=\"https://uk.reuters.com/article/uk-basf-outlook/basf-cuts-outlook-now-sees-profits-falling-15-20-percent-in-2018-idUKKBN1O629K\" target=\"_blank\">cutting its FY 2018 profit forecast</a>, blaming most of the decline on weakness in its chemicals segment, where prices for isocyanate - used in making polyurethane polymers and foams - and steam cracker margins were lower than expected.</li><li>BASF says it now expects full-year adjusted EBIT to decline by 15%-20% from  last year\u2019s 7.6B ($8.6B), compared to an earlier  forecast of a 10% drop.</li><li>The company, based on the Rhine, expects the low water level of  the river during Q4 will lead to negative earnings impacts of up to EUR200M, higher than  previously forecast; in Q3, the negative earnings impact from the low water level could be limited to ~EUR50M.</li><li>Also, BASF says its business with the automotive industry has continued to decline, with demand from customers in China slowing significantly, which the company says has been hurt by the trade conflict between the U.S. and China.</li><li>Chemical stocks are broadly lower: <a href='https://seekingalpha.com/symbol/TSE' title='Trinseo S.A.'>TSE</a> <font color=\"red\">-7.3%</font>, <a href='https://seekingalpha.com/symbol/HUN' title='Huntsman Corporation'>HUN</a> <font color=\"red\">-4.3%</font>, <a href='https://seekingalpha.com/symbol/DWDP' title='DowDuPont Inc.'>DWDP</a> <font color=\"red\">-4.1%</font>, <a href='https://seekingalpha.com/symbol/ASH' title='Ashland Inc.'>ASH</a> <font color=\"red\">-4%</font>, <a href='https://seekingalpha.com/symbol/CE' title='Celanese Corporation'>CE</a> <font color=\"red\">-3.4%</font>, <a href='https://seekingalpha.com/symbol/LYB' title='LyondellBasell Industries N.V.'>LYB</a> <font color=\"red\">-3.3%</font>, <a href='https://seekingalpha.com/symbol/WLKP' title='Westlake Chemical Partners LP'>WLKP</a> <font color=\"red\">-3.2%</font>, <a href='https://seekingalpha.com/symbol/EMN' title='Eastman Chemical Co.'>EMN</a> <font color=\"red\">-3.1%</font>, <a href='https://seekingalpha.com/symbol/WLK' title='Westlake Chemical Corporation'>WLK</a> <font color=\"red\">-2.7%</font>, <a href='https://seekingalpha.com/symbol/PPG' title='PPG Industries, Inc.'>PPG</a> <font color=\"red\">-2.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415398\" data-linked=\"BASF -4% after cutting 2018 profit outlook, now seen falling 15%-20%\" data-tweet=\"$BASFY $BASFY $TSE - BASF -4% after cutting 2018 profit outlook, now seen falling 15%-20% https://seekingalpha.com/news/3415398-basfminus-4-after-cutting-2018-profit-outlook-now-seen-falling-15minus-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3415398-basfminus-4-after-cutting-2018-profit-outlook-now-seen-falling-15minus-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415392\" data-ts=\"1544209155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLMT\" target=\"_blank\">CLMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415392-calumet-specialty-products-partners-and-genie-energy-among-energy-materials-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Calumet Specialty Products Partners and Genie Energy among Energy/Materials gainers; Ferrellgas Partners and Emerge Energy Services among losers</a></h4><ul><li><b>Gainers:Â </b>Calumet Specialty Products Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a>) <font color=\"green\">+9%</font>. Genie Energy (NYSE:<a href='https://seekingalpha.com/symbol/GNE' title='Genie Energy Ltd.'>GNE</a>) <font color=\"green\">+8%</font>. VAALCO Energy (NYSE:<a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a>) <font color=\"green\">+7%</font>. Legacy Reserves (NASDAQ:<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a>) <font color=\"green\">+7%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers:Â </b>Ferrellgas Partners (NYSE:<a href='https://seekingalpha.com/symbol/FGP' title='Ferrellgas Partners L.P'>FGP</a>) <font color=\"red\">-12%</font>. Emerge Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a>) <font color=\"red\">-7%</font>. Covia (NYSE:<a href='https://seekingalpha.com/symbol/CVIA' title='Covia Holdings Corporation'>CVIA</a>) <font color=\"red\">-6%</font>. Venator Materials PLC (NYSE:<a href='https://seekingalpha.com/symbol/VNTR' title='Venator Materials'>VNTR</a>) <font color=\"red\">-6%</font>. Tantech (NASDAQ:<a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415392\" data-linked=\"Calumet Specialty Products Partners and Genie Energy among Energy/Materials gainers; Ferrellgas Partners and Emerge Energy Services among losers\" data-tweet=\"$CLMT $CLMT $GNE - Calumet Specialty Products Partners and Genie Energy among Energy/Materials gainers; Ferrellgas Partners and Emerge Energy Services among losers https://seekingalpha.com/news/3415392-calumet-specialty-products-partners-and-genie-energy-among-energy-materials-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415392-calumet-specialty-products-partners-and-genie-energy-among-energy-materials-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415391\" data-ts=\"1544209021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACB\" target=\"_blank\">ACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415391-aurora-cannabis-to-enter-mexico-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurora Cannabis to enter Mexico; shares up 9%</a></h4><ul><li>Nano cap Aurora Cannabis (<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color=\"green\">+9.1%</font>) is up on modestly higher volume on the heels of its <a href=\"https://seekingalpha.com/pr/17352232-aurora-cannabis-enter-mexico-market-via-exclusive-supply-arrangement-farmacias-magistrales\" target=\"_blank\">announcement</a> that it will enter the Mexican market via an exclusive partnership with local drug maker Farmacias Magistrales S.A.</li><li>Farmacias has secured licenses from regulators for the importation and storage of raw cannabidiol &#40;CBD&#41; and THC materials and the manufacture and distribution of CBD- and THC-containing products.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415391\" data-linked=\"Aurora Cannabis to enter Mexico; shares up 9%\" data-tweet=\"$ACB - Aurora Cannabis to enter Mexico; shares up 9% https://seekingalpha.com/news/3415391-aurora-cannabis-to-enter-mexico-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3415391-aurora-cannabis-to-enter-mexico-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>84&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415417\" data-ts=\"1544208941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EOG\" target=\"_blank\">EOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415417-eog-resourcesplus-2-on-oil-rally-j-p-morgan-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EOG Resources +2% on oil rally, J.P. Morgan upgrade</a></h4><ul><li>EOGÂ Resources (<a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color=\"green\">+2.1%</font>) rides today's energy rally to a healthy gain, helped too by a J.P. Morgan <a href=\"https://thefly.com/thestreet/realmoney/index.php/EOG%3bDVN%3bCHKid2833572/EOG%3bDVN%3bCHK-JPMorgan-upgrades-EOG-Resources-to-Overweight-on-more-defensive-tilt\" target=\"_blank\">upgrade</a> to Overweight from Neutral with a $118 price target.</li><li>JPM analyst Arun Jayaram reshuffled his ratings for the large-cap E&amp;P segment to reflect changes in the macro environment, and he <a href=\"https://www.barrons.com/articles/the-surge-in-energy-stocks-isnt-going-to-last-analyst-says-1544199716\" target=\"_blank\">likes EOG's defensive characteristics</a> and expects the shares to outperform the peer group assuming oil prices remain near strip levels.</li><li>Jayaram also likes Permian producers Anadarko Petroleum (<a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color=\"green\">+0.8%</font>), Cabot Oil &amp;Â Gas (<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a>), Concho Resources (<a href='https://seekingalpha.com/symbol/CXO' title='Concho Resources Inc.'>CXO</a> <font color=\"green\">+1.2%</font>), Marathon Oil (<a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color=\"red\">-0.7%</font>) and Pioneer NaturalÂ Resources (<a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a>), believing the companies are \"solidly positioned over the long term\" although he expects \"significant pressure on estimates.\"</li><li>At the same time, the firm <a href=\"https://seekingalpha.com/news/3415352-chesapeake-energy-plus-3-percent-oil-rally-outweighs-j-p-morgan-downgrade\" target=\"_blank\">downgrades</a> Chesapeake Energy and Devon Energy, but those stocks also are higher.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415417\" data-linked=\"EOG Resources +2% on oil rally, J.P. Morgan upgrade\" data-tweet=\"$EOG $EOG $APC - EOG Resources +2% on oil rally, J.P. Morgan upgrade https://seekingalpha.com/news/3415417-eog-resourcesplus-2-on-oil-rally-j-p-morgan-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3415417-eog-resourcesplus-2-on-oil-rally-j-p-morgan-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415386\" data-ts=\"1544206766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TENX\" target=\"_blank\">TENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415386-tenax-prices-equity-offering-shares-ahead-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenax prices equity offering; shares ahead 38%</a></h4><ul><li>Ultra-thinly traded Tenax Therapeutics (<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a> <font color=\"green\">+38.1%</font>) is up on a whopping 1,614x surge in volume. The company just <a href=\"https://seekingalpha.com/pr/17352218-tenax-therapeutics-announces-pricing-10-million-underwritten-offering\" target=\"_blank\">announced </a>the pricing of its $10M equity offering of 5,181,346 Units at $1.93. Shares were up three-fold before retracing.</li><li>Each Unit consists of one share of Series A Convertible Preferred Stock, convertible into one share of common at $1.93, one two-year warrant to purchase one share of common at $1.93 and one five-year warrant to purchase one share of common at $1.93.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3414211-tenax-therapeutics-files-stock-offering\" target=\"_blank\">Tenax Therapeutics files for stock offering</a> (Dec. 4)</li><li><strong>Update</strong>: The offering <a href=\"https://seekingalpha.com/pr/17355228-tenax-therapeutics-announces-closing-10-million-underwritten-offering\" target=\"_blank\">closed </a>on December 11 yielding gross proceeds of ~$10M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415386\" data-linked=\"Tenax prices equity offering; shares ahead 38%\" data-tweet=\"$TENX - Tenax prices equity offering; shares ahead 38% https://seekingalpha.com/news/3415386-tenax-prices-equity-offering-shares-ahead-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3415386-tenax-prices-equity-offering-shares-ahead-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415384\" data-ts=\"1544206466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QRVO\" target=\"_blank\">QRVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415384-susquehanna-starts-qorvo-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna starts Qorvo at Neutral</a></h4><ul><li>Susquehanna <a href=\"https://www.streetinsider.com/New+Coverage/Susquehanna+Starts+Qorvo+Inc+%28QRVO%29+at+Neutral/14899011.html\" target=\"_blank\">initiates</a> Qorva (NASDAQ:<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a>) with a Neutral rating and a $70 price target.</li><li>Earlier this week, fellow Apple supplier joined Qorvo and Lumentum in cutting its guidance on soft smartphone demand.</li><li>Qorvo shares are down 1% to $62.10.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3414358-apple-suppliers-chips-drop-cirrus-cut\" target=\"_blank\">Apple suppliers, chips drop on Cirrus cut</a> (Dec. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415384\" data-linked=\"Susquehanna starts Qorvo at Neutral\" data-tweet=\"$QRVO - Susquehanna starts Qorvo at Neutral https://seekingalpha.com/news/3415384-susquehanna-starts-qorvo-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3415384-susquehanna-starts-qorvo-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415382\" data-ts=\"1544206171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZEN\" target=\"_blank\">ZEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415382-wedbush-starts-zendesk-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush starts Zendesk at Outperform</a></h4><ul><li>Wedbush <a href=\"https://www.streetinsider.com/New+Coverage/Wedbush+Starts+Zendesk+%28ZEN%29+at+Outperform/14899115.html\" target=\"_blank\">starts</a> Zendesk (<a href='https://seekingalpha.com/symbol/ZEN' title='Zendesk, Inc.'>ZEN</a> <font color='red'>-2.3%</font>) at Outperform with a $71 price target.</li><li>While the tech sector has had a rocky year between the US-China trade war and Apple iPhone demand fears, cloud stocks have faired better thanks to IBM's $34B Red Hat acquisition and the planned merger between Cloudera and Hortonworks.</li><li>Zendesk shares areÂ <font color=\"green\">up 4.3%</font>Â in the past week,Â <font color=\"green\">12.3%Â </font>in the month, andÂ <font color=\"green\">77%</font>Â YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415382\" data-linked=\"Wedbush starts Zendesk at Outperform\" data-tweet=\"$ZEN - Wedbush starts Zendesk at Outperform https://seekingalpha.com/news/3415382-wedbush-starts-zendesk-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3415382-wedbush-starts-zendesk-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415378\" data-ts=\"1544205574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OZM\" target=\"_blank\">OZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415378-och-ziff-capital-management-leads-financial-gainers-hexindai-and-lendingtree-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Och-Ziff Capital Management leads financial gainers; Hexindai and LendingTree among losers</a></h4><ul><li><b>Gainers:</b> Och-Ziff Capital Management Group (NYSE:<a href='https://seekingalpha.com/symbol/OZM' title='Och-Ziff Capital Management Group LLC'>OZM</a>) <font color=\"green\">+18%</font>. CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a>) <font color=\"green\">+6%</font>. Greenhill &amp; Co. (NYSE:<a href='https://seekingalpha.com/symbol/GHL' title='Greenhill & Co., Inc.'>GHL</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Jupai Holdings (NYSE:<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a>) <font color=\"red\">-32%</font>. Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"red\">-13%</font>. China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"red\">-11%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"red\">-11%</font>. LendingTree (NASDAQ:<a href='https://seekingalpha.com/symbol/TREE' title='LendingTree, Inc.'>TREE</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415378\" data-linked=\"Och-Ziff Capital Management leads financial gainers; Hexindai and LendingTree among losers\" data-tweet=\"$OZM $SCU $CBL - Och-Ziff Capital Management leads financial gainers; Hexindai and LendingTree among losers https://seekingalpha.com/news/3415378-och-ziff-capital-management-leads-financial-gainers-hexindai-and-lendingtree-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415378-och-ziff-capital-management-leads-financial-gainers-hexindai-and-lendingtree-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415376\" data-ts=\"1544205445\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415376-reuters-petrobras-nears-terms-over-tag-pipeline-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Petrobras nears terms over TAG pipeline sale</a></h4><ul><li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+2.2%</font>) could present a <a href=\"https://www.reuters.com/article/petrobras-pipeline/brazils-petrobras-nears-terms-over-tag-pipeline-sale-idUSL1N1YC0Z4\" target=\"_blank\">new sale and purchase agreement</a> before the end of this year for the sale of the Transportadora Associada de GÃ¡s pipeline, Reuters reports, after a U.S. Supreme Court injunction in July stalled the sale.</li><li>The sale of TAG reportedly could fetch as much as $7B, which would make it one of PBR\u2019s largest-ever asset sales.</li><li>A sale would mark a pullback from the natural gas distribution business for PBR, as the company prioritizes more profitable investments such as Brazil\u2019s deepwater oil and gas exploration and production segments, while divesting midstream assets such as refineries and pipelines, as well as overseas oil fields.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415376\" data-linked=\"Reuters: Petrobras nears terms over TAG pipeline sale\" data-tweet=\"$PBR - Reuters: Petrobras nears terms over TAG pipeline sale https://seekingalpha.com/news/3415376-reuters-petrobras-nears-terms-over-tag-pipeline-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3415376-reuters-petrobras-nears-terms-over-tag-pipeline-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415372\" data-ts=\"1544204899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TENX\" target=\"_blank\">TENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415372-microcaps-tops-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps tops midday movers</a></h4><ul><li><strong>Gainers:Â </strong>Tenax Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a>) <font color=\"green\">+129%</font>. Sears Hometown and Outlet Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/SHOS' title='Sears Hometown and Outlet Stores, Inc.'>SHOS</a>) <font color=\"green\">+22%</font>. Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) <font color=\"green\">+22%</font>. NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/NFEC' title='NF Energy Saving Corp.'>NFEC</a>) <font color=\"green\">+20%</font>. Domo (NASDAQ:<a href='https://seekingalpha.com/symbol/DOMO' title='Domo, Inc.'>DOMO</a>) <font color=\"green\">+20%</font>. VIVUS (NASDAQ:<a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a>) <font color=\"green\">+19%</font>. Comtech Telecommunications (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a>) <font color=\"green\">+18%</font>. Och-Ziff Capital Management Group (NYSE:<a href='https://seekingalpha.com/symbol/OZM' title='Och-Ziff Capital Management Group LLC'>OZM</a>) <font color=\"green\">+18%</font>. Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a>) <font color=\"green\">+14%</font>. Qualstar Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/QBAK' title='Qualstar Corporation'>QBAK</a>) <font color=\"green\">+15%</font>.</li> <li><strong>Losers:Â </strong>Jupai Holdings (NYSE:<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a>) <font color=\"red\">-32%</font>. Viveve Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a>) <font color=\"red\">-27%.Â </font>United Natural Foods (NYSE:<a href='https://seekingalpha.com/symbol/UNFI' title='United Natural Foods, Inc.'>UNFI</a>) <font color=\"red\">-24%</font>. Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>) <font color=\"red\">-23%</font>. Akorn (NASDAQ:<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a>) <font color=\"red\">-19%</font>. SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"red\">-16%</font>. Vail Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MTN' title='Vail Resorts, Inc.'>MTN</a>) <font color=\"red\">-16%</font>. ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='Endra Life Sciences Inc'>NDRA</a>) <font color=\"red\">-15%</font>. Oragenics (NYSEMKT:<a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a>) <font color=\"red\">-14%</font>. Adial Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a>) <font color=\"red\">-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415372\" data-linked=\"Microcaps tops midday movers\" data-tweet=\"$TENX $TENX $SHOS - Microcaps tops midday movers https://seekingalpha.com/news/3415372-microcaps-tops-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415372-microcaps-tops-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415371\" data-ts=\"1544204767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415371-lululemon-leads-apparel-sector-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon leads apparel sector lower</a></h4><ul> <li>Apparel and footwear stocks are trading weak once again, presumably on renewed tariff jitters from investors and some blowback from Lululemon's (<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='red'>-9.7%</font>)Â disappointing holiday quarter guidance.</li> <li>Notable decliners include VF Corp (NYSE:<a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a>) <font color=\"red\">-5.3%</font>, Michael Kors (KORS) <font color=\"red\">-5.1%</font>, Fossilk (NASDAQ:<a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a>)Â <font color=\"red\">-5.0%</font>, Tapestry (NYSE:<a href='https://seekingalpha.com/symbol/TPR' title='Tapestry, Inc.'>TPR</a>)Â <font color=\"red\">-4.7%</font>, Deckers Outdoor (NASDAQ:<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a>)Â <font color=\"red\">-4.2%</font>, Oxford Industries (NYSE:<a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries Inc.'>OXM</a>) <font color=\"red\">-4.0%</font>, PVH(NYSE:<a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a>) <font color=\"red\">-3.9%</font>, Vince (NYSE:<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a>) <font color=\"red\">-3.7%</font>, Vera Bradley (NASDAQ:<a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a>) <font color=\"red\">-3.6%</font>, Gildan ACtivewear (NYSE:<a href='https://seekingalpha.com/symbol/GIL' title='Gildan Activewear Inc.'>GIL</a>) <font color=\"red\">-2.9%</font>, Columbia SPortswear (NASDAQ:<a href='https://seekingalpha.com/symbol/COLM' title='Columbia Sportswear Company'>COLM</a>) <font color=\"red\">-2.7%</font>, Hanesbrands (NYSE:<a href='https://seekingalpha.com/symbol/HBI' title='Hanesbrands Inc.'>HBI</a>) <font color=\"red\">-2.6%</font> and Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a>) <font color=\"red\">-2.5%</font>.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3415123-lululemon-falls-6-percent-despite-earnings-topper\" target=\"_blank\">Lululemon falls 6% despite earnings topper</a> (Dec. 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415371\" data-linked=\"Lululemon leads apparel sector lower\" data-tweet=\"$LULU $LULU $VFC - Lululemon leads apparel sector lower https://seekingalpha.com/news/3415371-lululemon-leads-apparel-sector-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3415371-lululemon-leads-apparel-sector-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415368\" data-ts=\"1544203850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415368-vivus-joins-tiny-biotechs-in-green-up-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus joins tiny biotechs in the green, up 21%</a></h4><ul><li>Thinly traded nano cap Vivus (<a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a> <font color=\"green\">+21.3%</font>) is up on almost a 6x surge in volume, the latest member of spiking tiny biotechs.</li><li>The stock is currently exchanging hands at $2.98, well below its quick asset value per share based on Q3 numbers. At the end of September, cash and equivalents and available-for-sale securities totaled $115.1M or $10.83 per share. Operations consumed $26.7M during the first three quarters so, assuming similar cash consumption in Q4, the cash value per share will be ~$10 at year-end.</li><li>The company is planning to relaunch PANCREAZE next quarter. It also plans to obtain additional regulatory approvals and partners in open territories for STENDRA/SPEDRA and certain territories for QSYMIA (<a href=\"https://www.sec.gov/Archives/edgar/data/881524/000110465918070009/a18-40734_1ex99d1.htm\" target=\"_blank\">corporate presentation</a>, slide #19).</li></ul><div class=\"tiny-share-widget\" data-id=\"3415368\" data-linked=\"Vivus joins tiny biotechs in the green, up 21%\" data-tweet=\"$VVUS - Vivus joins tiny biotechs in the green, up 21% https://seekingalpha.com/news/3415368-vivus-joins-tiny-biotechs-in-green-up-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3415368-vivus-joins-tiny-biotechs-in-green-up-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415365\" data-ts=\"1544203378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AB\" target=\"_blank\">AB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415365-asset-managers-avoid-markets-downdraft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asset managers avoid the market&#39;s downdraft</a></h4><ul><li>Many asset managers are rising amid the broader market decline.</li><li>AllianceBernstein (<a href='https://seekingalpha.com/symbol/AB' title='AllianceBernstein Holding L.P.'>AB</a> <font color='green'>+2.5%</font>), Franklin Resources (<a href='https://seekingalpha.com/symbol/BEN' title='Franklin Resources Inc.'>BEN</a> <font color='green'>+1.2%</font>),Â  and exchange-traded product specialist Wisdom Tree (<a href='https://seekingalpha.com/symbol/WETF' title='WisdomTree Investments, Inc.'>WETF</a> <font color='green'>+1.1%</font>) manage the healthiest gains.</li><li>Och-Ziff Management (<a href='https://seekingalpha.com/symbol/OZM' title='Och-Ziff Capital Management Group LLC'>OZM</a> <font color='green'>+18.3%</font>) gains after outlining sweeping changes on Thursday that will lead to Dan Och transitioning out of the firm.</li><li>Not all are up though: BlackRock (<a href='https://seekingalpha.com/symbol/BLK' title='BlackRock, Inc.'>BLK</a> <font color='red'>-0.2%</font>) and Invesco (<a href='https://seekingalpha.com/symbol/IVZ' title='Invesco Ltd.'>IVZ</a> <font color='red'>-0.9%</font>) slip.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415334-skittish-markets-turn\" target=\"_blank\">Skittish markets turn down</a> (Dec. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415365\" data-linked=\"Asset managers avoid the market&#39;s downdraft\" data-tweet=\"$AB $AB $BEN - Asset managers avoid the market&#39;s downdraft https://seekingalpha.com/news/3415365-asset-managers-avoid-markets-downdraft?source=tweet\" data-url=\"https://seekingalpha.com/news/3415365-asset-managers-avoid-markets-downdraft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415364\" data-ts=\"1544203370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415364-tech-lunch-huawei-woes-weigh-down-wall-street\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech lunch: Huawei woes weigh down Wall Street</a></h4><ul><li>Tech weighs on Wall Street today, offsetting strong oil prices and a so-so jobs report that was good enough to avoid slowdown fears. The sector is still feeling pressure from the arrest of Huawei's CFO, with its potential to stoke new US-China trade tensions, and concerns about the Apple<font color=\"red\"> -2.5%Â </font>supply chain even as BroadcomÂ <font color=\"green\">+1.3%</font>Â gains after positive earnings.</li><li>The tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) and S&amp;P IT Index areÂ <font color=\"red\">down 2.5%</font>, the Nasdaq 100<font color=\"red\"> drops 2.3%</font>, and the Philadelphia Semiconductor IndexÂ <font color=\"red\">drops 2.5%</font>. The Dow, S&amp;P 500, and Nasdaq are downÂ <font color=\"red\">1.6%</font>,Â <font color=\"red\">1.6%</font>, andÂ <font color=\"red\">2%</font>, respectively.</li><li>Related broad tech ETFs: <a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>, <a href='https://seekingalpha.com/symbol/VGT' title='Vanguard Information Technology ETF'>VGT</a>, <a href='https://seekingalpha.com/symbol/TECL' title='Direxion Technology Bull 3x Shares ETF'>TECL</a>, <a href='https://seekingalpha.com/symbol/FTEC' title='Fidelity MSCI Information Technology Index ETF'>FTEC</a>, <a href='https://seekingalpha.com/symbol/IYW' title='iShares U.S. Technology ETF'>IYW</a>, <a href='https://seekingalpha.com/symbol/ROM' title='ProShares Ultra Technology ETF'>ROM</a>, <a href='https://seekingalpha.com/symbol/QTEC' title='First Trust NASDAQ-100-Tech Index ETF'>QTEC</a>, <a href='https://seekingalpha.com/symbol/RYT' title='Invesco S&P 500 Equal Weight Technology ETF'>RYT</a>, <a href='https://seekingalpha.com/symbol/FNG' title='AdvisorShares New Tech and Media ETF'>FNG</a>, <a href='https://seekingalpha.com/symbol/TECS' title='Direxion Technology Bear 3x Shares ETF'>TECS</a>, <a href='https://seekingalpha.com/symbol/IGM' title='iShares North American Tech ETF'>IGM</a>, <a href='https://seekingalpha.com/symbol/FXL' title='First Trust Tech AlphaDEX ETF'>FXL</a>, <a href='https://seekingalpha.com/symbol/XNTK' title='SPDR NYSE Technology ETF'>XNTK</a>, <a href='https://seekingalpha.com/symbol/REW' title='ProShares UltraShort Technology ETF'>REW</a>, <a href='https://seekingalpha.com/symbol/JHMT' title='John Hancock Multifactor Technology ETF'>JHMT</a>, <a href='https://seekingalpha.com/symbol/XITK' title='SPDR Innovative Technology ETF'>XITK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415364\" data-linked=\"Tech lunch: Huawei woes weigh down Wall Street\" data-tweet=\"$XLK $VGT $TECL - Tech lunch: Huawei woes weigh down Wall Street https://seekingalpha.com/news/3415364-tech-lunch-huawei-woes-weigh-down-wall-street?source=tweet\" data-url=\"https://seekingalpha.com/news/3415364-tech-lunch-huawei-woes-weigh-down-wall-street\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415362\" data-ts=\"1544203143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLND\" target=\"_blank\">TLND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415362-talend-to-acquire-stitch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Talend to acquire Stitch</a></h4><ul><li>Talend (<a href='https://seekingalpha.com/symbol/TLND' title='Talend SA'>TLND</a> <font color=\"green\">+5.3%</font>) has entered into a <a href=\"https://www.talend.com/about-us/press-releases/talend-acquires-stitch-a-leader-in-self-service-cloud-data-integration/\" target=\"_blank\">definitive agreement to acquire</a> Stitch for $60M in cash (subject to  certain transaction adjustments).</li><li>Stitch offers an easy-to-use service for moving data from popular sources to leading cloud data warehouse platforms.</li><li>The transaction is expected to close in Q4 and subject to customary closing conditions.</li><li>\u201cStitch is a great addition that gives us a compelling offering in the market for simple, self-service integration for cloud data warehouses,\u201d said Mike Tuchen, CEO, Talend. \u201cIn addition, we believe Stitch will work as an efficient high-volume way to acquire new cloud customers to whom we can market our advanced cloud solutions for data integration, transformation, cleaning, preparing and cataloging.\u201d</li></ul><div class=\"tiny-share-widget\" data-id=\"3415362\" data-linked=\"Talend to acquire Stitch\" data-tweet=\"$TLND - Talend to acquire Stitch https://seekingalpha.com/news/3415362-talend-to-acquire-stitch?source=tweet\" data-url=\"https://seekingalpha.com/news/3415362-talend-to-acquire-stitch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415358\" data-ts=\"1544201986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAYRY\" target=\"_blank\">BAYRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415358-activist-investor-elliott-takes-on-bayer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activist investor Elliott takes on Bayer</a></h4><ul><li>Reuters <a href=\"https://www.reuters.com/article/us-bayer-elliott/activist-investor-elliott-has-taken-position-in-germanys-bayer-sources-idUSKBN1O61ZR\" target=\"_blank\">reports </a>that activist investor Paul Singer's Elliott Management has established a larger stake in Bayer (<a href='https://seekingalpha.com/symbol/BAYRY' title='Bayer A.G. ADR'>OTCPK:BAYRY</a> <font color=\"green\">+0.1%</font>) after owning the stock for more than a year. Mr. Singer has been unable to meet personally with CEO Werner Baumann or one of his colleagues so a more sizeable position, unspecified at this point, may open the executive suite a bit.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415358\" data-linked=\"Activist investor Elliott takes on Bayer\" data-tweet=\"$BAYRY - Activist investor Elliott takes on Bayer https://seekingalpha.com/news/3415358-activist-investor-elliott-takes-on-bayer?source=tweet\" data-url=\"https://seekingalpha.com/news/3415358-activist-investor-elliott-takes-on-bayer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415357\" data-ts=\"1544201965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAAS\" target=\"_blank\">CAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415357-china-automotive-systems-leads-consumer-gainers-eastman-kodak-and-lululemon-athletica-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Automotive Systems leads consumer gainers; Eastman Kodak and Lululemon Athletica among losers</a></h4><ul><li><b>Gainers:</b> China Automotive Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a>) <font color=\"green\">+11%</font>. Thor Industries (NYSE:<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a>) <font color=\"green\">+6%</font>. SunOpta (NASDAQ:<a href='https://seekingalpha.com/symbol/STKL' title='SunOpta, Inc.'>STKL</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Johnson Outdoors (NASDAQ:<a href='https://seekingalpha.com/symbol/JOUT' title='Johnson Outdoors Inc.'>JOUT</a>) <font color=\"red\">-18%</font>. Lululemon Athletica (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) <font color=\"red\">-8%</font>. Movado Group (NYSE:<a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a>) <font color=\"red\">-8%</font>. Eastman Kodak (NYSE:<a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a>) <font color=\"red\">-6%</font>. At Home Group (NASDAQ:<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group'>HOME</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415357\" data-linked=\"China Automotive Systems leads consumer gainers; Eastman Kodak and Lululemon Athletica among losers\" data-tweet=\"$CAAS $CAAS $THO - China Automotive Systems leads consumer gainers; Eastman Kodak and Lululemon Athletica among losers https://seekingalpha.com/news/3415357-china-automotive-systems-leads-consumer-gainers-eastman-kodak-and-lululemon-athletica-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3415357-china-automotive-systems-leads-consumer-gainers-eastman-kodak-and-lululemon-athletica-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415356\" data-ts=\"1544201891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PARR\" target=\"_blank\">PARR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415356-par-pacificplus-3-oppenheimer-starts-coverage-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Par Pacific +3% as Oppenheimer starts coverage at Outperform</a></h4><ul><li>Par Pacific (<a href='https://seekingalpha.com/symbol/PARR' title='Par Pacific Holdings, Inc.'>PARR</a> <font color='green'>+3.1%</font>) is higher as Oppenheimer initiates the stock with an <a href=\"https://thefly.com/thestreet/realmoney/index.php/PARRid2833392/PARR-Par-Pacific-initiated-with-an-Outperform-at-Oppenheimer\" target=\"_blank\">Outperform rating</a> and $22 price target, saying the company's self-described \"growth-oriented\" profile is supported  by \"several transformation acquisitions and growth projects underway  that are dramatically reshaping the company.\"</li><li>Oppenheimer analyst Tim Rezvan notes that what was once a one-off Hawaii refinery with interests in a private E&amp;P should soon be an integrated, three-refinery network processing 170K bbl/day of crude, with estimated $65M of annual logistics EBITDA and $80M of free cash flow per year with mid-cycle crack spreads.</li><li>The firm also expects the company's acquisitions and \"tactical capital investments to optimize revenue opportunities\" going forward.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415356\" data-linked=\"Par Pacific +3% as Oppenheimer starts coverage at Outperform\" data-tweet=\"$PARR - Par Pacific +3% as Oppenheimer starts coverage at Outperform https://seekingalpha.com/news/3415356-par-pacificplus-3-oppenheimer-starts-coverage-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3415356-par-pacificplus-3-oppenheimer-starts-coverage-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415353\" data-ts=\"1544201371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKRX\" target=\"_blank\">AKRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415353-akorn-loses-appeal-of-fresenius-exit-from-merger-shares-down-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akorn loses appeal of Fresenius exit from merger; shares down 22%</a></h4><ul><li>Akorn (<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color=\"red\">-22%</font>) is down on almost quadruple normal volume in response to its <a href=\"https://courts.delaware.gov/Opinions/Download.aspx?id=282110\" target=\"_blank\">failed appeal</a> of Fresenius SE's exit from the now-defunct merger.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3414906-akorn-7-percent-premarket-slim-chances-reviving-fresenius-deal\" target=\"_blank\">Akorn down 7% premarket on slim chances of reviving Fresenius deal</a> (Dec. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415353\" data-linked=\"Akorn loses appeal of Fresenius exit from merger; shares down 22%\" data-tweet=\"$AKRX - Akorn loses appeal of Fresenius exit from merger; shares down 22% https://seekingalpha.com/news/3415353-akorn-loses-appeal-of-fresenius-exit-from-merger-shares-down-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3415353-akorn-loses-appeal-of-fresenius-exit-from-merger-shares-down-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415352\" data-ts=\"1544201230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415352-chesapeake-energyplus-3-oil-rally-outweighs-j-p-morgan-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy +3% as oil rally outweighs J.P. Morgan downgrade</a></h4><ul><li>Chesapeake Energy (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"green\">+3.5%</font>) bounces off 10-month lows as today's rally in crude oil prices outweighs <a href=\"https://www.marketwatch.com/story/chesapeake-energys-stock-bounces-as-oil-price-jump-offsets-jp-morgans-bearish-call-2018-12-07\" target=\"_blank\">J.P. Morgan's downgrade</a> of CHK shares to Underweight from Neutral, citing concerns over near-term headwinds from the company's planned <a href=\"https://seekingalpha.com/news/3402528-chesapeake-energy-buy-wildhorse-4b-cash-stock-deal\" target=\"_blank\">$4B acquisition</a> of WildHorse Resource.</li><li>While the acquisition, which provided increased oil weightings, was a \"necessary step\" for CHK in turning the corner on its turnaround plan, \"the stock will likely be a 'show me' situation\" as investors generally had mixed views on the east Texas Eagle Ford plays, JPM analyst Arun Jayaram says.</li><li>The firm also issues several other downgrades to reflect the \"sharp retrenchment\" in oil prices.</li><li>Cut to Neutral from Overweight: Devon Energy (NYSE:<a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a>), Gulfport Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/GPOR' title='Gulfport Energy Corporation'>GPOR</a>), Matador Resources (NYSE:<a href='https://seekingalpha.com/symbol/MTDR' title='Matador Resources'>MTDR</a>) and SCRÂ Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/SRCI' title='SRC Energy Inc.'>SRCI</a>).</li><li>Downgraded to Underweight from Neutral, in addition to CHK: Carrizo Oil &amp;Â Gas (NASDAQ:<a href='https://seekingalpha.com/symbol/CRZO' title='Carrizo Oil & Gas, Inc.'>CRZO</a>) and Halcon Resources (NYSE:<a href='https://seekingalpha.com/symbol/HK' title='Halcon Resources Corporation'>HK</a>).</li><li>Cut by two notches to Underweight from Overweight: Extraction Oil &amp;Â Gas (NASDAQ:<a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas'>XOG</a>) and High Point Resources (NYSE:<a href='https://seekingalpha.com/symbol/HPR' title='HighPoint Resources Corporation'>HPR</a>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3415352\" data-linked=\"Chesapeake Energy +3% as oil rally outweighs J.P. Morgan downgrade\" data-tweet=\"$CHK $CHK $DVN - Chesapeake Energy +3% as oil rally outweighs J.P. Morgan downgrade https://seekingalpha.com/news/3415352-chesapeake-energyplus-3-oil-rally-outweighs-j-p-morgan-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3415352-chesapeake-energyplus-3-oil-rally-outweighs-j-p-morgan-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415350\" data-ts=\"1544200913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APHA\" target=\"_blank\">APHA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415350-short-seller-citron-likes-aphria-sees-70-upside-shares-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Short seller Citron likes Aphria, sees 70% upside; shares up 7%</a></h4><ul><li>Pot stock Aphria (<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a> <font color=\"green\">+7%</font>) is up on robust turnover of almost 20M shares on the heels of Altria Group's 45% stake in Cronos Group.</li><li>Adding a bit of fuel to the buying is a <a href=\"https://twitter.com/CitronResearch/status/1071061967505305601\" target=\"_blank\">bullish call</a> from heretofore-short seller Citron Research who says Altria's action warrants a \"rethink\" on pot stock valuations, adding that APHA is a compelling candidate considering its large Canadian footprint and fair value target of $10 per share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415350\" data-linked=\"Short seller Citron likes Aphria, sees 70% upside; shares up 7%\" data-tweet=\"$APHA - Short seller Citron likes Aphria, sees 70% upside; shares up 7% https://seekingalpha.com/news/3415350-short-seller-citron-likes-aphria-sees-70-upside-shares-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3415350-short-seller-citron-likes-aphria-sees-70-upside-shares-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>129&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415346\" data-ts=\"1544200343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/K\" target=\"_blank\">K</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415346-kellogg-partners-on-cornflakes-beer-mashup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kellogg partners on cornflakes-beer mashup</a></h4><ul> <li>Kellogg (<a href='https://seekingalpha.com/symbol/K' title='Kellogg Company'>K</a> <font color='red'>-0.7%</font>) is teaming up with UK's Seven Bro7thers Brewery to <a href=\"https://www.telegraph.co.uk/news/2018/12/05/kelloggs-use-rejected-cornflakes-make-beer-bid-cut-food-waste/\" target=\"_blank\">convert</a> extra cornflakes into a beer called Throw Away IPA.</li> <li>The cornflakes are added during the mash up process and end up accounting for about 30% of the grain content of the beer.</li> <li>Though small in scale, the company sees the partnership as a sustainable way to reduce food waste.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415346\" data-linked=\"Kellogg partners on cornflakes-beer mashup\" data-tweet=\"$K - Kellogg partners on cornflakes-beer mashup https://seekingalpha.com/news/3415346-kellogg-partners-on-cornflakes-beer-mashup?source=tweet\" data-url=\"https://seekingalpha.com/news/3415346-kellogg-partners-on-cornflakes-beer-mashup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415345\" data-ts=\"1544199761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTA\" target=\"_blank\">ULTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415345-wells-fargos-read-on-ulta-beauty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo&#39;s read on Ulta Beauty</a></h4><ul> <li>Wells Fargo sticks with an Outperform rating on Ultra Beauty (<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a> <font color='red'>-9.7%</font>) after taking in the retailer's Q3 earnings report and conference call.</li> <li>\"Management sounded cautiously optimistic heading into the thick of the holiday season (noting that the competitive environment is robust but stable), while we remain confident in ULTA's ability to deliver comps in their targeted range as they begin to lever FY18 investments next year,\" writes analyst Ike Boruchow and team.</li><li>\"We believe investors should keep their eye on the long-term path today, as we continue to regard ULTA as a best-in-class retailer.\"</li> <li>Wells has a 2018 EPS estimate of $10.88 on ULTA and 2019 EPS estimate of $12.62. WF's price target of $328 on Ulta is 22X the firm's 2020 EPS estimate.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415091-ulta-beauty-beats-0_02-revenue-line\" target=\"_blank\">Ulta Beauty beats by $0.02,  revenue in-line</a> (Dec. 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415098-comp-sales-8-percent-ulta-beauty\" target=\"_blank\">Comp sales up 8% at Ulta Beauty</a> (Dec. 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415345\" data-linked=\"Wells Fargo&#39;s read on Ulta Beauty\" data-tweet=\"$ULTA - Wells Fargo&#39;s read on Ulta Beauty https://seekingalpha.com/news/3415345-wells-fargos-read-on-ulta-beauty?source=tweet\" data-url=\"https://seekingalpha.com/news/3415345-wells-fargos-read-on-ulta-beauty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415343\" data-ts=\"1544199296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415343-tonix-pharma-prices-equity-offering-shares-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix Pharma prices equity offering; shares down 5%</a></h4><ul><li>Investors now know the reason behind the early jump in Tonix Pharmaceuticals (<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color=\"red\">-5.1%</font>). The company has <a href=\"https://seekingalpha.com/pr/17352111-tonix-pharmaceuticals-prices-15000-000-public-offering\" target=\"_blank\">priced </a>its $15M public offering of Class A Units at $3.50 each and Class B Units at $1,000 each.</li><li>Each Class A Unit consists of one share of common stock and one five-year warrant to purchase one share of common at $3.50.</li><li>Each Class B Unit consists of one share of Series A Convertible Preferred Stock, convertible into 286 common shares, valued at $1,000 per share and five-year warrants to purchase 286 common shares at $3.50.</li><li>Yesterday's close was $3.15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415343\" data-linked=\"Tonix Pharma prices equity offering; shares down 5%\" data-tweet=\"$TNXP - Tonix Pharma prices equity offering; shares down 5% https://seekingalpha.com/news/3415343-tonix-pharma-prices-equity-offering-shares-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3415343-tonix-pharma-prices-equity-offering-shares-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415339\" data-ts=\"1544198418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TENX\" target=\"_blank\">TENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415339-cronos-group-and-aphria-among-healthcare-gainers-viveve-medical-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cronos Group and Aphria among healthcare gainers; Viveve Medical leads the losers</a></h4><ul><li><b>Gainers:</b> Tenax Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a>) <font color=\"green\">+162%</font>. Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"green\">+60%</font>. Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) <font color=\"green\">+22%</font>. Kodiak Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/KOD' title='Kodiak Sciences'>KOD</a>) <font color=\"green\">+11%</font>. Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"green\">+10%</font>.</li><li><b>Losers:</b> Viveve Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a>) <font color=\"red\">-25%</font>. Oragenics (NYSEMKT:<a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a>) <font color=\"red\">-15%</font>. MiMedx Group (<a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a>) <font color=\"red\">-10%</font>. Fresenius Medical Care (NYSE:<a href='https://seekingalpha.com/symbol/FMS' title='Fresenius Medical Care AG & Co. KGAA'>FMS</a>) <font color=\"red\">-9%</font>. NovaBay Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/NBY' title='NovaBay Pharmaceuticals, Inc.'>NBY</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415339\" data-linked=\"Cronos Group and Aphria among healthcare gainers; Viveve Medical leads the losers\" data-tweet=\"$TENX $TENX $TNXP - Cronos Group and Aphria among healthcare gainers; Viveve Medical leads the losers https://seekingalpha.com/news/3415339-cronos-group-and-aphria-among-healthcare-gainers-viveve-medical-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415339-cronos-group-and-aphria-among-healthcare-gainers-viveve-medical-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415340\" data-ts=\"1544198345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQNR\" target=\"_blank\">EQNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415340-equinor-s-troll-expansion-project-gets-government-ok\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Equinor\u2019s Troll expansion project gets government OK</a></h4><ul><li>Equinor (<a href='https://seekingalpha.com/symbol/EQNR' title='Equinor ASA'>EQNR</a> <font color='green'>+2.8%</font>) says it has <a href=\"https://www.reuters.com/article/us-equinor-troll/equinor-gets-ok-to-extend-troll-gasfield-lifetime-beyond-2050-idUSKBN1O610O\" target=\"_blank\">received approval</a> from Norway's government for its plan to increase production and extend the lifetime of the Troll offshore oil and gas field.</li><li>EQNR says the NOK7.8B ($915M) Phase 3 development will help to produce an extra 2.2B boe and extend gas production beyond 2050.</li><li>\u201cWith a break-even of less than $10/bbl, Troll Phase 3 is one of the most profitable and resilient projects ever in our company,\u201d says the company's senior VP for the project.</li><li>The field accounts for ~40% of the natural gas reserves on the Norwegian continental shelf and meets 7%-8% of Europe\u2019s consumption.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415340\" data-linked=\"Equinor\u2019s Troll expansion project gets government OK\" data-tweet=\"$EQNR - Equinor\u2019s Troll expansion project gets government OK https://seekingalpha.com/news/3415340-equinor-s-troll-expansion-project-gets-government-ok?source=tweet\" data-url=\"https://seekingalpha.com/news/3415340-equinor-s-troll-expansion-project-gets-government-ok\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415337\" data-ts=\"1544197768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCM\" target=\"_blank\">HCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415337-small-healthcare-stocks-shrug-off-broad-market-selling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Small healthcare stocks shrug off broad market selling</a></h4><ul><li>Money flow has picked over the past two weeks in micro/small cap healthcare stocks after the recent selloff. Many will need to raise new capital in 2019, however.</li><li>A sampling of today's action: (<a href='https://seekingalpha.com/symbol/HCM' title='Hutchison China MediTech Ltd.'>HCM</a> <font color=\"green\">+4.6%</font>)(<a href='https://seekingalpha.com/symbol/IVC' title='Invacare Corporation'>IVC</a> <font color=\"green\">+6.9%</font>)(<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color=\"green\">+2.8%</font>)(<a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color=\"green\">+4.3%</font>)(<a href='https://seekingalpha.com/symbol/AGLE' title='Aeglea BioTherapeutics'>AGLE</a> <font color=\"green\">+2.6%</font>)(<a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color=\"green\">+8.4%</font>)(<a href='https://seekingalpha.com/symbol/ALIM' title='Alimera Sciences, Inc.'>ALIM</a> <font color=\"green\">+4.5%</font>)(<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a> <font color=\"green\">+2.7%</font>)(<a href='https://seekingalpha.com/symbol/BCLI' title='BrainStorm Cell Therapeutics Inc.'>BCLI</a> <font color=\"green\">+3.3%</font>)(<a href='https://seekingalpha.com/symbol/CFRX' title='ContraFect Corp.'>CFRX</a> <font color=\"green\">+5.8%</font>)(<a href='https://seekingalpha.com/symbol/CNCE' title='Concert Pharmaceuticals, Inc.'>CNCE</a> <font color=\"green\">+2.6%</font>)(<a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics'>CDTX</a> <font color=\"green\">+0.8%</font>)(<a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a> <font color=\"green\">+3.9%</font>)(<a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a> <font color=\"green\">+6.8%</font>)(<a href='https://seekingalpha.com/symbol/CYAD' title='Celyad'>CYAD</a> <font color=\"green\">+5.9%</font>)(<a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color=\"green\">+5.9%</font>)(<a href='https://seekingalpha.com/symbol/CLBS' title='Caladrius Biosciences, Inc.'>CLBS</a> <font color=\"green\">+2.1%</font>)(<a href='https://seekingalpha.com/symbol/OSIR' title='Osiris Therapeutics, Inc.'>OSIR</a> <font color=\"green\">+3.2%</font>)(<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a> <font color=\"green\">+3.9%</font>)(<a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a> <font color=\"green\">+4.3%</font>)(<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a> <font color=\"green\">+2.5%</font>)(<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a> <font color=\"green\">+7.4%</font>)(<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color=\"green\">+4.6%</font>)(<a href='https://seekingalpha.com/symbol/MEIP' title='MEI Pharma, Inc.'>MEIP</a> <font color=\"green\">+4.3%</font>)(<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Co.'>LJPC</a> <font color=\"green\">+5.3%</font>)(<a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color=\"green\">+4.4%</font>)(<a href='https://seekingalpha.com/symbol/MRUS' title='Merus'>MRUS</a> <font color=\"green\">+4.7%</font>)(<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a> <font color=\"green\">+1.8%</font>)(<a href='https://seekingalpha.com/symbol/ITCI' title='Intra-Cellular Therapies Inc.'>ITCI</a> <font color=\"green\">+9.2%</font>)(<a href='https://seekingalpha.com/symbol/HEB' title='Hemispherx Biopharma, Inc'>HEB</a> <font color=\"green\">+3.1%</font>)(<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a> <font color=\"green\">+5.1%</font>)(<a href='https://seekingalpha.com/symbol/ISR' title='IsoRay, Inc.'>ISR</a> <font color=\"green\">+3.7%</font>)(<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color=\"green\">+60.3%</font>)(<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a> <font color=\"green\">+12.3%</font>)(<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a> <font color=\"green\">+159.5%</font>)(<a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a> <font color=\"green\">+6.8%</font>)(<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color=\"green\">+3.5%</font>)(<a href='https://seekingalpha.com/symbol/REPH' title='Recro Pharma Inc'>REPH</a> <font color=\"green\">+3.3%</font>)(<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color=\"green\">+5.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415337\" data-linked=\"Small healthcare stocks shrug off broad market selling\" data-tweet=\"$HCM $HCM $IVC - Small healthcare stocks shrug off broad market selling https://seekingalpha.com/news/3415337-small-healthcare-stocks-shrug-off-broad-market-selling?source=tweet\" data-url=\"https://seekingalpha.com/news/3415337-small-healthcare-stocks-shrug-off-broad-market-selling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415336\" data-ts=\"1544197552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDC\" target=\"_blank\">CLDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415336-china-lending-corporation-launches-new-supply-chain-financing-services\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Lending Corporation launches new supply chain financing services</a></h4><ul><li>China Lending Corporation (<a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+9.4%</font>) says that the company has <a href=\"https://seekingalpha.com/pr/17352020-china-lending-corporation-launches-new-supply-chain-financing-services\" target=\"_blank\">expanded its service offerings</a> with the launch of its new supply chain financing services including business factoring program.</li><li>The Program aims to provide owners of SMEs with liquidity to finance operations and growth.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415336\" data-linked=\"China Lending Corporation launches new supply chain financing services\" data-tweet=\"$CLDC - China Lending Corporation launches new supply chain financing services https://seekingalpha.com/news/3415336-china-lending-corporation-launches-new-supply-chain-financing-services?source=tweet\" data-url=\"https://seekingalpha.com/news/3415336-china-lending-corporation-launches-new-supply-chain-financing-services\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415333\" data-ts=\"1544197313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOI\" target=\"_blank\">SOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415333-solaris-oilfieldplus-5-after-initiating-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solaris Oilfield +5% after initiating dividend</a></h4><ul><li>Solaris Oilfield Infrastructure (<a href='https://seekingalpha.com/symbol/SOI' title='Solaris Oilfield Infrastructure'>SOI</a> <font color=\"green\">+4.7%</font>) shoots higher after <a href=\"https://seekingalpha.com/pr/17351681-solaris-oilfield-infrastructure-initiates-quarterly-cash-dividend\" target=\"_blank\">declaring its first quarterly cash dividend</a> of $0.10/share, to be paid on Dec. 27 to holders of record as of Dec. 17.</li><li>Solaris says the move reflects confidence that it has \"reached a scale where we can begin to return cash to our shareholders while also continuing to invest in our growth and preserve our conservative balance sheet.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3415333\" data-linked=\"Solaris Oilfield +5% after initiating dividend\" data-tweet=\"$SOI - Solaris Oilfield +5% after initiating dividend https://seekingalpha.com/news/3415333-solaris-oilfieldplus-5-after-initiating-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3415333-solaris-oilfieldplus-5-after-initiating-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415332\" data-ts=\"1544196821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIX\" target=\"_blank\">EIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415332-edison-lifts-dividend-still-probing-involvement-in-southern-california-wildfire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edison lifts dividend, still probing involvement in Southern California wildfire</a></h4><ul><li>Edison International (<a href='https://seekingalpha.com/symbol/EIX' title='Edison International'>EIX</a> <font color='green'>+2.1%</font>) moves higher after <a href=\"https://seekingalpha.com/pr/17351674-edison-international-declares-common-stock-dividend\" target=\"_blank\">raising its quarterly dividend</a> to $0.6125/share from $0.605 and <a href=\"https://seekingalpha.com/pr/17351673-sce-publicly-releases-cpuc-submission-woolsey-fire\" target=\"_blank\">releasing its latest incident report</a> on last month's Woolsey Fire to California regulators.</li><li>In its evaluation of whether a power failure near the start of the Woolsey Fire was related to contact between wires, Southern California Edison said its <a href=\"https://finance.yahoo.com/news/edison-reviewing-wire-contact-start-232435324.html\" target=\"_blank\">crews found a guy wire</a>, used to support power poles, near a jumper, which connects two energized lines, at a circuit that failed ahead of the blaze, but no live wires were found on the ground at the site.</li><li>California investigators have not determined the cause of the Woolsey Fire, and EIX also has not determined the cause of the outage on its circuit.</li><li>SoCal Edison is facing increased scrutiny for the wildfire that burned ~100K acres and destroyed 1,500 structures in and around Malibu last month; EIX shares have dropped 17% since the Nov. 8 start of the Southern California fire.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415332\" data-linked=\"Edison lifts dividend, still probing involvement in Southern California wildfire\" data-tweet=\"$EIX - Edison lifts dividend, still probing involvement in Southern California wildfire https://seekingalpha.com/news/3415332-edison-lifts-dividend-still-probing-involvement-in-southern-california-wildfire?source=tweet\" data-url=\"https://seekingalpha.com/news/3415332-edison-lifts-dividend-still-probing-involvement-in-southern-california-wildfire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415331\" data-ts=\"1544196624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415331-natural-gas-inventory-declines-in-line-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory declines in-line with estimates</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>-63 Bcf</strong> vs. -64 Bcf consensus, -59 Bcf last week.</li><li>FuturesÂ <font color=\"green\">+3.05%</font>Â to $4.459.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a> en</li></ul><div class=\"tiny-share-widget\" data-id=\"3415331\" data-linked=\"Natural gas inventory declines in-line with estimates\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory declines in-line with estimates https://seekingalpha.com/news/3415331-natural-gas-inventory-declines-in-line-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3415331-natural-gas-inventory-declines-in-line-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415329\" data-ts=\"1544196302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZUMZ\" target=\"_blank\">ZUMZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415329-zumiezminus-3_7-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zumiez -3.7% post Q3 results</a></h4><ul><li>Zumiez (<a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a> <font color=\"red\">-3.7%</font>) reports <a href=\"https://seekingalpha.com/pr/17351607-zumiez-inc-announces-fiscal-2018-third-quarter-results\" target=\"_blank\">Q3</a> revenue growth of 1.2% Y/Y to $248.8M &amp; 4.8% increase in comparable sales.</li><li>Gross margin <font color=\"green\">increased 100 bps</font> Y/Y to 34.9% &amp; Operating margin <font color=\"red\">dropped 25 bps</font> to 7.4%.</li><li>The Company had cash and current marketable securities of $127.9M (+49.1% Y/Y).</li><li>The Company has opened 12 new stores this year, including 5 stores in North America; 7 stores in Europe &amp; plan to open one more store in 2018.</li><li><b>4Q 2018 Outlook:</b> Net sales of $295-301M; EPS of $1.02-1.08; comparable sale to grow 0-2%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415118-zumiez-beats-0_10-revenue-line\" target=\"_blank\">Zumiez beats by $0.10,  revenue in-line</a> (Dec. 06 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415329\" data-linked=\"Zumiez -3.7% post Q3 results\" data-tweet=\"$ZUMZ - Zumiez -3.7% post Q3 results https://seekingalpha.com/news/3415329-zumiezminus-3_7-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3415329-zumiezminus-3_7-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415326\" data-ts=\"1544195813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRMD\" target=\"_blank\">CRMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415326-cormedix-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CorMedix up 7%</a></h4><ul><li>CorMedix (<a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a> <font color=\"green\">+7%</font>) is up on modestly higher volume in early trade. Shares have rallied overÂ <font color=\"green\">90%</font>Â since touching $0.95 on November 12.</li><li>About a month ago, it filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1410098/000165495418012823/crmd_424b5.htm\" target=\"_blank\">prospectus supplement</a> for a $25M at-the-market stock sale agreement with B. Riley FBR.</li><li>At the end of September, it had $6.4M in cash and equivalents while operations consumed $16.5M during the first three quarters of the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415326\" data-linked=\"CorMedix up 7%\" data-tweet=\"$CRMD - CorMedix up 7% https://seekingalpha.com/news/3415326-cormedix-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3415326-cormedix-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415322\" data-ts=\"1544195208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOV\" target=\"_blank\">HOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415322-home-purchasing-sentiment-index-gains-half-point-in-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Home Purchasing Sentiment Index gains half a point in November</a></h4><ul><li>Fannie Mae November Home Purchasing Sentiment IndexÂ  creeps up 0.5 points to 86.2, as survey participants' household incomes gained offsetting potential cooling factors in the housing market.</li><li>\"Consumers' perceptions of growth in their household income reached a survey high this month, helping to absorb some of the impact of increasing mortgage rates on housing market activity,\" says Fannie Mae Chief Economist Doug Duncan.</li><li>iShares U.S. Home Construction ETF (BATS:<a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>)<font color=\"green\"> jumps 1.4%</font>.</li><li>The net share of those who say their household income is significantly higher than it was a year ago rose 5 percentage points M/M to a survey high of 24%.</li><li>Net share of Americans who say it's a good time to buy a home rose 2 pp to 23%.</li><li>The net share of those who say home prices will go up fell by 4 pp to 33%, down for the second straight month.</li><li>Among individual stocks: Hovnanian Enterprises (<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a> <font color='green'>+3.4%</font>), Lennar (<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color='green'>+2.7%</font>), William Lyon Homes (<a href='https://seekingalpha.com/symbol/WLH' title='William Lyon Homes'>WLH</a> <font color='green'>+2.5%</font>), Beazer Homes (<a href='https://seekingalpha.com/symbol/BZH' title='Beazer Homes USA, Inc.'>BZH</a> <font color='green'>+1.3%</font>),Â  KB Homes (<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a> <font color='green'>+2.6%</font>), PulteGroup (<a href='https://seekingalpha.com/symbol/PHM' title='PulteGroup, Inc.'>PHM</a> <font color='green'>+1.1%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415001-homebuilders-timber-reits-gain-mortgage-rates-slip\" target=\"_blank\">Homebuilders, timber REITs gain as mortgage rates slip</a> (Dec. 6)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a>, <a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>, <a href='https://seekingalpha.com/symbol/PKB' title='Invesco Dynamic Building & Construction Portfolio ETF'>PKB</a>, <a href='https://seekingalpha.com/symbol/NAIL' title='Direxion Daily Homebuilders & Supplies Bull 3x Shares ETF'>NAIL</a>, <a href='https://seekingalpha.com/symbol/HOML' title='ETRACS Monthly Reset 2xLeveraged ISE Exclusively Homebuilders ETN'>HOML</a>, <a href='https://seekingalpha.com/symbol/CLAW' title='Direxion Daily Homebuilders & Supplies Bear 3x Shares ETF'>CLAW</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415322\" data-linked=\"Home Purchasing Sentiment Index gains half a point in November\" data-tweet=\"$HOV $ITB $HOV - Home Purchasing Sentiment Index gains half a point in November https://seekingalpha.com/news/3415322-home-purchasing-sentiment-index-gains-half-point-in-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3415322-home-purchasing-sentiment-index-gains-half-point-in-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415321\" data-ts=\"1544195111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLSE\" target=\"_blank\">PLSE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415321-pulse-bio-completes-rights-offering-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pulse Bio completes rights offering; shares up 4%</a></h4><ul><li>Pulse Biosciences (<a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color=\"green\">+3.6%</font>) has <a href=\"https://seekingalpha.com/pr/17352038-pulse-biosciences-inc-announces-oversubscription-pricing-preliminary-results-45-million\" target=\"_blank\">completed </a>its overprescribed rights offering for ~3.6M common shares at $12.5658. The distribution will take place on or about December 14.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415321\" data-linked=\"Pulse Bio completes rights offering; shares up 4%\" data-tweet=\"$PLSE - Pulse Bio completes rights offering; shares up 4% https://seekingalpha.com/news/3415321-pulse-bio-completes-rights-offering-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3415321-pulse-bio-completes-rights-offering-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415316\" data-ts=\"1544194802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415316-oppenheimer-defends-lululemons-premium-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer defends Lululemon&#39;s premium valuation</a></h4><ul> <li>Oppenheimer stays positive on Lululemomn (<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='red'>-3.1%</font>) after digesting the retailer's \"impressive\" Q3 report that showed solid comparable sales and margin gains.</li> <li>Analyst Brian Nagel: \"A meaningful shift to a more digital distribution focus and market strategy is working together with improved product innovation to drive outsized sales and margin expansion at the chain. We remain confident that a solid, if not further fundamental strengthening, will support the stock's premium valuation.\"</li> <li>Oppenheimer has a 12-18 month price target of $190 on LULU off EPS estimates of $3.71 for FY18, $4.42 for FY19 and $5.35 for FY20.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415123-lululemon-falls-6-percent-despite-earnings-topper\" target=\"_blank\">Lululemon falls 6% despite earnings topper</a> (Dec. 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415229-lululemon-expand-loyalty-program-test\" target=\"_blank\">Lululemon to expand loyalty program test</a> (Dec. 7)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415316\" data-linked=\"Oppenheimer defends Lululemon&#39;s premium valuation\" data-tweet=\"$LULU - Oppenheimer defends Lululemon&#39;s premium valuation https://seekingalpha.com/news/3415316-oppenheimer-defends-lululemons-premium-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3415316-oppenheimer-defends-lululemons-premium-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415315\" data-ts=\"1544194796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415315-qualcomm-apple-settlement-coming-one-way-another\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm: Apple settlement coming &quot;one way or another&quot;</a></h4><ul><li>Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) President Cristiano Amon tells <a href=\"https://finance.yahoo.com/news/apple-qualcomm-battle-nearing-end-one-way-another-says-qualcomm-president-115736073.html\" target=\"_blank\">Yahoo Finance </a>that an end to the Apple legal battle is coming \"one way or another.\"</li><li>Amon:Â \u201cWe feel like we are probably near the end of this game \u2014 we have a lot of legal milestones approaching. We see 2019 as having events that will drive resolution one way or another.\u201d</li><li>Qualcomm shares areÂ <font color=\"red\">down 1.4%</font>Â to $56.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415315\" data-linked=\"Qualcomm: Apple settlement coming &quot;one way or another&quot;\" data-tweet=\"$QCOM - Qualcomm: Apple settlement coming &quot;one way or another&quot; https://seekingalpha.com/news/3415315-qualcomm-apple-settlement-coming-one-way-another?source=tweet\" data-url=\"https://seekingalpha.com/news/3415315-qualcomm-apple-settlement-coming-one-way-another\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415306\" data-ts=\"1544192987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIDS\" target=\"_blank\">KIDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415306-orthopediatrics-prices-stock-offering-27-shares-down-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OrthoPediatrics prices stock offering at $27; shares down 9% premarket</a></h4><ul><li>OrthoPediatrics (NASDAQ:<a href='https://seekingalpha.com/symbol/KIDS' title='OrthoPediatrics Corp.'>KIDS</a>) <a href=\"https://seekingalpha.com/pr/17352052-orthopediatrics-corp-announces-pricing-offering-common-stock\" target=\"_blank\">prices </a>its 1.5M-share stock offering at $27 per share. Underwriters over-allotment is an additional 225K shares. Closing date is December 11.</li><li>The stock is downÂ <font color=\"red\">9%</font>Â premarket on light volume.</li><li><strong>Update</strong>: The offering <a href=\"https://seekingalpha.com/pr/17355222-orthopediatrics-corp-announces-closing-common-stock-offering-full-exercise-underwriters\" target=\"_blank\">closed </a>on December 11 yielding gross proceeds of ~$46.6M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415306\" data-linked=\"OrthoPediatrics prices stock offering at $27; shares down 9% premarket\" data-tweet=\"$KIDS - OrthoPediatrics prices stock offering at $27; shares down 9% premarket https://seekingalpha.com/news/3415306-orthopediatrics-prices-stock-offering-27-shares-down-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3415306-orthopediatrics-prices-stock-offering-27-shares-down-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415304\" data-ts=\"1544192611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBT\" target=\"_blank\">GBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415304-global-blood-prices-stock-offering-shares-down-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Blood prices stock offering; shares down 6% premarket</a></h4><ul><li>Global Blood Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a>) is downÂ <font color=\"red\">6%</font>Â premarket on modest volume following its <a href=\"https://seekingalpha.com/pr/17352043-global-blood-therapeutics-prices-150_0-million-common-stock-public-offering\" target=\"_blank\">announcement </a>that it has \"priced\" its $150M stock offering. Specifically, underwriters will sell shares from time to time at market prices or through negotiated transactions which may be below market at that particular time.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415304\" data-linked=\"Global Blood prices stock offering; shares down 6% premarket\" data-tweet=\"$GBT - Global Blood prices stock offering; shares down 6% premarket https://seekingalpha.com/news/3415304-global-blood-prices-stock-offering-shares-down-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3415304-global-blood-prices-stock-offering-shares-down-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415300\" data-ts=\"1544192088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415300-rig-cgc-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RIG, CGC among premarket gainers</a></h4><ul><li>Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"green\">+67%</font>Â on <a href=\"https://seekingalpha.com/news/3415259-tonix-pharma-111-percent-premarket\" target=\"_blank\">no news</a>.</li><li>Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) <font color=\"green\">+31%</font>Â as pot stocks set to <a href=\"https://seekingalpha.com/news/3415234-pot-stocks-set-rally-altria-1_8b-investment-cronos-group\" target=\"_blank\">rally</a> after Altria $1.8B investment.</li><li>Tenax Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a>) <font color=\"green\">+28%</font>Â on <a href=\"https://seekingalpha.com/news/3415263-tenax-therapeutics-32-percent-premarket\" target=\"_blank\">no news</a>.</li><li>NTN Buzztime (NYSEMKT:<a href='https://seekingalpha.com/symbol/NTN' title='NTN Buzztime, Inc'>NTN</a>) <font color=\"green\">+19%</font>Â on <a href=\"https://seekingalpha.com/pr/17351957-ntn-buzztime-exploring-strategic-alternatives\" target=\"_blank\">exploring</a> strategic alternatives.</li><li>American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>) <font color=\"green\">+13%</font>Â on Q2 <a href=\"https://seekingalpha.com/news/3415094-american-outdoor-brands-beats-0_06-beats-revenue\" target=\"_blank\">result</a>.</li><li>Zealand Pharma A/S (NASDAQ:<a href='https://seekingalpha.com/symbol/ZEAL' title='Zealand Pharma'>ZEAL</a>) <font color=\"green\">+9%</font>.</li><li>Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"green\">+8%</font>Â as pot stocks set toÂ <a href=\"https://seekingalpha.com/news/3415234-pot-stocks-set-rally-altria-1_8b-investment-cronos-group\" target=\"_blank\">rally</a>Â after Altria $1.8B investment.</li><li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) <font color=\"green\">+8%</font>Â as pot stocks set toÂ <a href=\"https://seekingalpha.com/news/3415234-pot-stocks-set-rally-altria-1_8b-investment-cronos-group\" target=\"_blank\">rally</a>Â after Altria $1.8B investment.</li><li>Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a>) <font color=\"green\">+7%</font>.</li><li>Ensco plc (NYSE:<a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a>) <font color=\"green\">+7%</font>.</li><li>Denbury Resources (NYSE:<a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a>) <font color=\"green\">+6%</font>.</li><li>Whiting Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a>) <font color=\"green\">+6%</font>.</li><li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) <font color=\"green\">+6%</font>Â as pot stocks set toÂ <a href=\"https://seekingalpha.com/news/3415234-pot-stocks-set-rally-altria-1_8b-investment-cronos-group\" target=\"_blank\">rally</a>Â after Altria $1.8B investment.</li><li>Alliqua BioMedical (NASDAQ:<a href='https://seekingalpha.com/symbol/ALQA' title='Alliqua BioMedical, Inc.'>ALQA</a>) <font color=\"green\">+5%</font>.</li><li>Transocean (NYSE:<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a>) <font color=\"green\">+5%</font>.</li><li>Corbus Pharmaceuticals Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a>) <font color=\"green\">+5%</font>Â on <a href=\"https://seekingalpha.com/news/3415255-rbc-sees-three-bagger-corbus-pharma\" target=\"_blank\">positive upgrade</a>.</li><li>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415300\" data-linked=\"RIG, CGC among premarket gainers\" data-tweet=\"$TNXP $TNXP $CRON - RIG, CGC among premarket gainers https://seekingalpha.com/news/3415300-rig-cgc-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415300-rig-cgc-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415299\" data-ts=\"1544192075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415299-u-s-crude-oilplus-5-opec-reportedly-reaches-production-cut-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. crude oil +5% as OPEC reportedly reaches production cut deal</a></h4><ul><li>Crude oil futures are now surging on reports that OPEC has struck a deal to cut production: WTIÂ <font color=\"green\">+4.9%</font> to $54.03/bbl, Brent <font color=\"green\">+5.2%</font> to $63.19/bbl.</li><li>Iraq's oil minister says OPEC members agree to cut ~800K bbl/day with non-OPEC allies including Russia asked to cut 400K bbl/day for combined reductions of 1.2M bbl/day, with October oil output as the deal's baseline; the agreement will last for six months, to be reviewed in April.</li><li>Iran was granted an exemption from the cuts since it is under sanctions from the U.S.; Libya and Venezuela also are exempt.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/ERYY' title='Direxion Daily Energy Bear 1x Shares ETF'>ERYY</a>, <a href='https://seekingalpha.com/symbol/ERGF' title='iShares Edge MSCI Multifactor Energy ETF'>ERGF</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415299\" data-linked=\"U.S. crude oil +5% as OPEC reportedly reaches production cut deal\" data-tweet=\"$USO $XLE $OIL - U.S. crude oil +5% as OPEC reportedly reaches production cut deal https://seekingalpha.com/news/3415299-u-s-crude-oilplus-5-opec-reportedly-reaches-production-cut-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3415299-u-s-crude-oilplus-5-opec-reportedly-reaches-production-cut-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415296\" data-ts=\"1544191894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JP\" target=\"_blank\">JP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415296-jp-and-big-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JP and BIG among premarket losers</a></h4><ul><li>Jupai Holdings (NYSE:<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a>)Â <font color=\"red\">-27%</font>Â on <a href=\"https://seekingalpha.com/news/3415198-jupai-holdings-reports-q3-results\" target=\"_blank\">Q3 earnings</a>.</li><li>Viveve Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a>)Â <font color=\"red\">-25%</font>Â on <a href=\"https://seekingalpha.com/news/3415217-viveve-prices-common-stock-offering-shares-16-percent-premarket\" target=\"_blank\">pricing</a> stock offering.</li><li>Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>)Â <font color=\"red\">-19%</font>Â on <a href=\"https://seekingalpha.com/news/3415207-big-lots-misses-0_16-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>United Natural Foods (NYSE:<a href='https://seekingalpha.com/symbol/UNFI' title='United Natural Foods, Inc.'>UNFI</a>)Â <font color=\"red\">-10%</font>Â on <a href=\"https://seekingalpha.com/news/3415097-united-natural-foods-misses-0_14-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Oragenics (NYSEMKT:<a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a>) <font color=\"red\">-11%</font>.</li><li>Global Blood Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a>)Â <font color=\"red\">-7%</font>Â on <a href=\"https://seekingalpha.com/news/3415115-global-blood-launches-150m-stock-offering-shares-4-percent-hours\" target=\"_blank\">launching</a> $150M stock offering.</li><li>Quotient (NASDAQ:<a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a>)Â <font color=\"red\">-6%</font>Â on <a href=\"https://seekingalpha.com/news/3415220-quotient-prices-common-stock-offering\" target=\"_blank\">pricing</a> stock offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415296\" data-linked=\"JP and BIG among premarket losers\" data-tweet=\"$JP $JP $VIVE - JP and BIG among premarket losers https://seekingalpha.com/news/3415296-jp-and-big-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415296-jp-and-big-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415280\" data-ts=\"1544190607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415280-morgan-stanley-trims-apple-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley trims its Apple target</a></h4><ul><li>Morgan Stanley<a href=\"https://www.cnbc.com/2018/12/07/morgan-stanley-joins-the-chorus-of-apple-price-target-cuts.html\" target=\"_blank\"> cuts</a> its Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) price target from $253 to $236.</li><li>Analyst Katy Huberty cites a weak market in China for iPhones due to longer replacement cycles, echoing a trend in the United States.</li><li>Huberty has historically leaned bullish on Apple particularly on Services potential.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3409961-buy-apple-supplier-pullback-morgan-stanley\" target=\"_blank\">Buy Apple on supplier pullback - Morgan Stanley</a> (Nov. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415280\" data-linked=\"Morgan Stanley trims its Apple target\" data-tweet=\"$AAPL - Morgan Stanley trims its Apple target https://seekingalpha.com/news/3415280-morgan-stanley-trims-apple-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3415280-morgan-stanley-trims-apple-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>85&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415273\" data-ts=\"1544189917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCAU\" target=\"_blank\">FCAU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415273-fiat-to-make-new-grand-cherokee-in-detroit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fiat to make new Grand Cherokee in Detroit</a></h4><ul> <li>There's more information out on Fiat Chrysler Automobile's (NYSE:<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a>) plans in Detroit.</li> <li>The automaker plans to <a href=\"https://www.detroitnews.com/story/business/autos/chrysler/2018/12/06/fiat-chrysler-open-new-assembly-plant-detroit/2225735002/\" target=\"_blank\">convert</a> the Mack Avenue Engine II plant in the city to manufacture a new three-row Jeep Grand Cherokee for model year 2021, sources tell The Detroit News. Construction is expected to start next year.</li> <li>Fiat's plans in Detroit follow shortly after General Motor's (NYSE:<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a>) announcement that it would be idling four U.S. plants.</li> <li>\"FCA is essentially out of capacity,\" says LMC Automotive's Jeff Schuster on the development. \"They\u2019re kind of running up against being against full capacity. This is a very different situation than what GM is dealing with,\" he adds.</li><li>Fiat is coming off a strong month in the U.S., with unit sales up 17% driven by a 44% pop for Ram vehicles.</li><li>FCAUÂ <font color=\"red\">-1.87%</font>Â premarket to $15.70.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415073-fiat-plans-new-suv-plant-detroit\" target=\"_blank\">Fiat plans for new SUV plant in Detroit</a> (Dec. 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415273\" data-linked=\"Fiat to make new Grand Cherokee in Detroit\" data-tweet=\"$FCAU $FCAU $GM - Fiat to make new Grand Cherokee in Detroit https://seekingalpha.com/news/3415273-fiat-to-make-new-grand-cherokee-in-detroit?source=tweet\" data-url=\"https://seekingalpha.com/news/3415273-fiat-to-make-new-grand-cherokee-in-detroit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415272\" data-ts=\"1544189641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNC\" target=\"_blank\">SSNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415272-needham-names-ss-and-c-top-pick-for-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham names SS&amp;C top pick for 2019</a></h4><ul><li>Needham <a href=\"https://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Upgrades+SS%26C+Technologies+Holdings%2C+Inc.+%28SSNC%29+to+Strong+Buy/14901045.html\" target=\"_blank\">upgrades </a>SS&amp;C Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SSNC' title='SS&C Technologies Holdings, Inc.'>SSNC</a>) from Buy to Strong Buy and increases the target by $2 to $70.</li><li>AnalystÂ Mayank Tandon cites the firm's \"forecast of sustained strong EPS growth fueled by solid trends in the core business and acquisition synergies, and a valuation near historical lows.\"</li><li>The firm raises its FY19 and FY20 EPS estimates and names SS&amp;C as its top pick for 2019.</li><li>SS&amp;C shares areÂ <font color=\"green\">up 1.1%</font>Â premarket to $47.46.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415272\" data-linked=\"Needham names SS&amp;C top pick for 2019\" data-tweet=\"$SSNC - Needham names SS&amp;C top pick for 2019 https://seekingalpha.com/news/3415272-needham-names-ss-and-c-top-pick-for-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3415272-needham-names-ss-and-c-top-pick-for-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415265\" data-ts=\"1544189107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCWX\" target=\"_blank\">SCWX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415265-analysts-downgrade-secureworks-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts downgrade SecureWorks after earnings</a></h4><ul><li>RBC Capital <a href=\"https://www.streetinsider.com/Analyst+Comments/RBC+Capital+Downgrades+SecureWorks+%28SCWX%29+to+Sector+Perform/14900611.html\" target=\"_blank\">downgrades </a>SecureWorks (NASDAQ:<a href='https://seekingalpha.com/symbol/SCWX' title='SecureWorks Corp.'>SCWX</a>) from Outperform to Sector Perform but raises the price target by $4 to $18.</li><li>Analyst Matthew Hedberg sees the risk/reward as balanced and cites YTD performance, the stock trading in-line with peers, weaker MRR results and guidance, the \"lumpy\" NA enterprise business, and potential uncertainty with Marriott's recent data breach. A <a href=\"https://www.forbes.com/sites/thomasbrewster/2018/12/03/revealed-marriotts-500-million-hack-came-after-a-string-of-security-breaches/#19649434546f\" target=\"_blank\">Forbes source</a> tied a SecureWorks mistake to a 2017 breach at Marriott.</li><li>More action: First Analysis <a href=\"https://www.streetinsider.com/Analyst+Comments/First+Analysis+Downgrades+SecureWorks+%28SCWX%29+to+Neutral/14900564.html\" target=\"_blank\">downgrades</a> SecureWorks from Outperform to Neutral. KeyBanc <a href=\"https://www.streetinsider.com/Downgrades/KeyBanc+Downgrades+SecureWorks+%28SCWX%29+to+Sector+Weight/14897958.html\" target=\"_blank\">downgrades </a>SCWX from Overweight to Sector Weight.</li><li>SecureWorks shares areÂ <font color=\"green\">up 1.8%</font>Â premarket to $17.41.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3414837-securework-reports-q3-beats-raises-fy-guidance\" target=\"_blank\">SecureWork reports Q3 beats, raises FY guidance</a> (Dec. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415265\" data-linked=\"Analysts downgrade SecureWorks after earnings\" data-tweet=\"$SCWX - Analysts downgrade SecureWorks after earnings https://seekingalpha.com/news/3415265-analysts-downgrade-secureworks-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3415265-analysts-downgrade-secureworks-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415264\" data-ts=\"1544189034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415264-buying-action-on-new-age-beverages\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buying action on New Age Beverages</a></h4><ul> <li>Shares of New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) are <font color=\"green\">up 6.49%</font> in premarket trading to follow on yesterday's 4.37% gain.</li> <li>The early buying action has pushed shares of the beverage company back over $5.</li><li>The 52-week trading range on NBEV is $1.30 to $9.99.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3415264\" data-linked=\"Buying action on New Age Beverages\" data-tweet=\"$NBEV - Buying action on New Age Beverages https://seekingalpha.com/news/3415264-buying-action-on-new-age-beverages?source=tweet\" data-url=\"https://seekingalpha.com/news/3415264-buying-action-on-new-age-beverages\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415263\" data-ts=\"1544188874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TENX\" target=\"_blank\">TENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415263-tenax-therapeutics-up-32-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenax Therapeutics up 32% premarket</a></h4><ul><li>Ultra-thinly traded nano cap Tenax Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a>) is upÂ <font color=\"green\">32%</font>Â premarket on increased volume, albeit on turnover of only ~21K shares, on no readily apparent news.</li><li>Yesterday, it filed a <a href=\"https://seekingalpha.com/filing/4260105\" target=\"_blank\">registration statement</a> for a public offering of stock and warrants.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415263\" data-linked=\"Tenax Therapeutics up 32% premarket\" data-tweet=\"$TENX - Tenax Therapeutics up 32% premarket https://seekingalpha.com/news/3415263-tenax-therapeutics-up-32-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3415263-tenax-therapeutics-up-32-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415262\" data-ts=\"1544188631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415262-iran-reportedly-agrees-to-opec-deal-sending-crude-oil-prices-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iran reportedly agrees to OPEC deal, sending crude oil prices higher</a></h4><ul><li>Crude oil futures move higher on reports that <a href=\"https://twitter.com/ReutersBiz/status/1071027618701557760\" target=\"_blank\">Iran has finally agreed</a> to an OPEC deal in principle: WTIÂ <font color=\"green\">+1.6%</font> to $52.31/bbl, Brent <font color=\"green\">+2.1%</font> to $61.34/bbl.</li><li>Iran had appeared to be the main obstacle for an OPEC deal to cut  oil production, as Saudi Arabia had not agreed to the country's request for exemptions due to U.S. sanctions.</li><li>Still to be determined are the size of the overall production cut and Russia's contribution.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/ERYY' title='Direxion Daily Energy Bear 1x Shares ETF'>ERYY</a>, <a href='https://seekingalpha.com/symbol/ERGF' title='iShares Edge MSCI Multifactor Energy ETF'>ERGF</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415262\" data-linked=\"Iran reportedly agrees to OPEC deal, sending crude oil prices higher\" data-tweet=\"$USO $XLE $OIL - Iran reportedly agrees to OPEC deal, sending crude oil prices higher https://seekingalpha.com/news/3415262-iran-reportedly-agrees-to-opec-deal-sending-crude-oil-prices-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3415262-iran-reportedly-agrees-to-opec-deal-sending-crude-oil-prices-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415260\" data-ts=\"1544188325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MO\" target=\"_blank\">MO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415260-altria-group-backs-away-from-vaping-products\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altria Group backs away from vaping products</a></h4><ul><li>Altria Group (NYSE:<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a>) <a href=\"https://seekingalpha.com/pr/17351905-altria-refocuses-innovative-product-efforts\" target=\"_blank\">announces </a>that it will discontinue the development and distribution of all MarkTen and Green Smoke e-vapor products and VERVE oral nicotine-containing products, citing their expected financial performance and the current regulatory environment.</li><li>It says it will refocus its resources on more compelling reduced-risk tobacco opportunities.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/PM' title='Philip Morris International Inc.'>PM</a>, <a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c. &#40;American Depository Receipts&#41;'>BTI</a>, <a href='https://seekingalpha.com/symbol/IMBBF' title='Imperial Brands PLC'>OTCQX:IMBBF</a>, <a href='https://seekingalpha.com/symbol/JAPAY' title='Japan Tobacco ADR'>OTCPK:JAPAY</a>, <a href='https://seekingalpha.com/symbol/VGR' title='Vector Group Ltd.'>VGR</a>, <a href='https://seekingalpha.com/symbol/TPB' title='Turning Point Brands'>TPB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415260\" data-linked=\"Altria Group backs away from vaping products\" data-tweet=\"$MO $MO $PM - Altria Group backs away from vaping products https://seekingalpha.com/news/3415260-altria-group-backs-away-from-vaping-products?source=tweet\" data-url=\"https://seekingalpha.com/news/3415260-altria-group-backs-away-from-vaping-products\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415259\" data-ts=\"1544187963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415259-tonix-pharma-up-111-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix Pharma up 111% premarket</a></h4><ul><li>Nano cap Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) is upÂ <font color=\"green\">111%</font>Â premarket on increased volume on no readily apparent news. Yesterday, it filed a <a href=\"https://seekingalpha.com/news/3415052-tonix-pharma-files-upsized-equity-offering-shares-dow-19-percent\" target=\"_blank\">preliminary prospectus</a> for an offering of ~2.1M Class A Units and 9,000 Class B Units.</li><li>A couple of weeks ago, it <a href=\"https://seekingalpha.com/news/3413107-tonix-go-new-late-stage-study-tonmya-ptsd-shares-26-percent-premarket\" target=\"_blank\">announced </a>that the FDA agreed with the design of a new Phase 3 study evaluating Tonmya (cyclobenzaprine HCl sublingual tablets) for posttraumatic stress disorder &#40;PTSD&#41;.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415259\" data-linked=\"Tonix Pharma up 111% premarket\" data-tweet=\"$TNXP - Tonix Pharma up 111% premarket https://seekingalpha.com/news/3415259-tonix-pharma-up-111-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3415259-tonix-pharma-up-111-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415254\" data-ts=\"1544187199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOMO\" target=\"_blank\">MOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415254-morgan-stanley-slashes-momo-target-on-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley slashes Momo target on earnings</a></h4><ul><li>Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Morgan+Stanley+Downgrades+Momo+Inc.+%28MOMO%29+to+Equalweight/14900581.html\" target=\"_blank\">downgrades</a> Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a>) from Overweight to Equal Weight and drops the target from $61 to $30.</li><li>Momo sharesÂ <font color=\"red\">plunged 14.6%</font>Â yesterday after reporting Q3 earnings with downside guidance.</li><li>Momo shares areÂ <font color=\"red\">down 1.3%</font>Â premarket to $26.70.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3414755-momo-beats-0_07-beats-revenue\" target=\"_blank\">Momo beats by $0.07, beats on revenue</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415254\" data-linked=\"Morgan Stanley slashes Momo target on earnings\" data-tweet=\"$MOMO - Morgan Stanley slashes Momo target on earnings https://seekingalpha.com/news/3415254-morgan-stanley-slashes-momo-target-on-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3415254-morgan-stanley-slashes-momo-target-on-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415252\" data-ts=\"1544187071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JP\" target=\"_blank\">JP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415252-jupai-wilts-q3-margin-contracts-due-to-wary-investors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jupai wilts as Q3 margin contracts due to wary investors</a></h4><ul><li>Junpai Holdings (NYSE:<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a>)Â <font color=\"red\">dives 20%</font>Â in premarket trading after fiscal Q3 adjusted net income per diluted ADS sinks to RMB 0.73 ($0.11) from RMB 3.69 a year ago.</li><li>Q3 adjusted net margin attributableÂ  to ordinary shareholders shrinks to 8.2% from 28.6% a year ago.</li><li>Faced with an uncertain economic outlook in China, investors have become more cautious, the company says. Aggregate value of wealth management products distributed by Jupai during first nine months of its fiscal year fell by 33% to RMB 25.9B from a year ago, the company says.</li><li>Q3 net revenue fell 30% to RMB 310.6M (US$45.2M) from RMB 440.8M a year ago.</li><li>Total assets under management as of Sept. 30, 2018 were RMB 57.8B (US$8.4B), up 1.9% from June 30, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415198-jupai-holdings-reports-q3-results\" target=\"_blank\">Jupai Holdings reports Q3 results</a> (Dec. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415252\" data-linked=\"Jupai wilts as Q3 margin contracts due to wary investors\" data-tweet=\"$JP - Jupai wilts as Q3 margin contracts due to wary investors https://seekingalpha.com/news/3415252-jupai-wilts-q3-margin-contracts-due-to-wary-investors?source=tweet\" data-url=\"https://seekingalpha.com/news/3415252-jupai-wilts-q3-margin-contracts-due-to-wary-investors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415249\" data-ts=\"1544186635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415249-jefferies-turns-bullish-on-tesla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies turns bullish on Tesla</a></h4><ul> <li>Jefferies upgrades Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) to a Buy rating from Hold on confidence that the company's balance sheet is improving and productivity is cycling higher.</li> <li>\"The shares have done well since Q3 but, with Tesla having demonstrated its profit and self-funding potential, its growth becomes value-accretive just as peers are engaging in a mostly negative EV sum game,\" notes the firm.</li> <li>The analyst team also points to Tesla's \"broader price points, battery security of supply, product edge and a brand that transcends the volume/premium divide.\"</li> <li>Jefferies increases its price target on Tesla to $450 from $360. The average PT on the Street is $324.</li> <li>Shares of Tesla are <font color=\"green\">up 1.90%</font> in premarket trading to $369.79.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3415249\" data-linked=\"Jefferies turns bullish on Tesla\" data-tweet=\"$TSLA - Jefferies turns bullish on Tesla https://seekingalpha.com/news/3415249-jefferies-turns-bullish-on-tesla?source=tweet\" data-url=\"https://seekingalpha.com/news/3415249-jefferies-turns-bullish-on-tesla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>227&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415246\" data-ts=\"1544186146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPD\" target=\"_blank\">EXPD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415246-expeditors-downgraded-to-sell-goldman-headwinds-looming-in-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Expeditors downgraded to Sell at Goldman with headwinds looming in 2019</a></h4><ul><li>Expeditors International (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPD' title='Expeditors International of Washington, Inc.'>EXPD</a>) <font color=\"red\">-2.5%</font> pre-market after Goldman Sachs <a href=\"https://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+Expeditors+Intl+%28EXPD%29+to+Sell/14900538.html\" target=\"_blank\">downgrades shares to Sell</a> from Neutral with a $68 price target, expecting earnings pressure from a continued slowdown in the air freight  business and structural headwinds in ocean freight.</li><li>EXPD also has elevated exposure to U.S.-China trade tensions,  which along with \"deteriorating fundamentals\" and \"rich valuations\" likely will send shares lower in 2019, Goldman's Matt Reustle writes.</li><li>The firm attributes the recent outperformance in EXPD shares, which have gained 16% from their Oct. 24 trough, partially to factor investment drivers such as low volatility and no debt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415246\" data-linked=\"Expeditors downgraded to Sell at Goldman with headwinds looming in 2019\" data-tweet=\"$EXPD - Expeditors downgraded to Sell at Goldman with headwinds looming in 2019 https://seekingalpha.com/news/3415246-expeditors-downgraded-to-sell-goldman-headwinds-looming-in-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3415246-expeditors-downgraded-to-sell-goldman-headwinds-looming-in-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415245\" data-ts=\"1544186140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSP\" target=\"_blank\">INSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415245-inspire-medical-systems-prices-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inspire Medical Systems prices stock offering</a></h4><ul> <li>Inspire Medical Systems (NYSE:<a href='https://seekingalpha.com/symbol/INSP' title='Inspire Medical Systems, Inc.'>INSP</a>) <a href=\"https://seekingalpha.com/pr/17351786-inspire-medical-systems-inc-announces-pricing-offering-common-stock\" target=\"_blank\">prices</a> its previously announced offering of 2.5M shares of common stock at a price of $40 per share.</li><li>Underwriters over-allotment is an additional 375,000 shares.</li><li>Inspire will not receive any proceeds from the sale of common stock by the Selling Stockholders.</li><li>Closing date is December 11.</li><li>Shares are downÂ <font color=\"red\">2%</font>Â premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3414340-inspire-medical-systems-announces-proposed-offering-common-stock\" target=\"_blank\">Inspire Medical Systems announces proposed offering of common stock</a> (Dec. 4)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3415245\" data-linked=\"Inspire Medical Systems prices stock offering\" data-tweet=\"$INSP - Inspire Medical Systems prices stock offering https://seekingalpha.com/news/3415245-inspire-medical-systems-prices-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3415245-inspire-medical-systems-prices-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415234\" data-ts=\"1544185644\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRON\" target=\"_blank\">CRON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415234-pot-stocks-set-to-rally-after-altria-1_8b-investment-in-cronos-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pot stocks set to rally after Altria $1.8B investment in Cronos Group</a></h4><ul><li>Cannabis companies are set for a bullish day after Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) announced a $1.8B investment from Altria Group.</li><li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) and Tilray (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>) are upÂ <font color=\"green\">2%Â </font>andÂ <font color=\"green\">4%</font>, respectively, premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415233-cronos-group-shares-halted-pending-news\" target=\"_blank\">Cronos Group shares halted pending news</a> (Dec. 7)</li><li>Selected tickers: <a href='https://seekingalpha.com/symbol/MJNA' title='Medical Marijuana, Inc.'>OTCPK:MJNA</a>, <a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>, <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>, <a href='https://seekingalpha.com/symbol/PHOT' title='Growlife Inc.'>OTCQB:PHOT</a>, <a href='https://seekingalpha.com/symbol/CBIS' title='Cannabis Science, Inc.'>OTCPK:CBIS</a>, <a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>, <a href='https://seekingalpha.com/symbol/TRTC' title='Terra Tech Corp.'>OTCQX:TRTC</a>, <a href='https://seekingalpha.com/symbol/CANN' title='General Cannabis Corp.'>OTCQX:CANN</a>, <a href='https://seekingalpha.com/symbol/ERBB' title='American Green, Inc.'>OTCPK:ERBB</a>, <a href='https://seekingalpha.com/symbol/GRNH' title='GreenGro Technologies, Inc.'>OTCPK:GRNH</a>, <a href='https://seekingalpha.com/symbol/PMCB' title='PharmaCyte Biotech, Inc.'>OTCQB:PMCB</a>, <a href='https://seekingalpha.com/symbol/CVSI' title='CV Sciences, Inc.'>OTCQB:CVSI</a>, <a href='https://seekingalpha.com/symbol/FITX' title='Creative Edge Nutrition, Inc.'>OTC:FITX</a>, <a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a>, <a href='https://seekingalpha.com/symbol/HEMP' title='Hemp, Inc.'>OTCPK:HEMP</a>, <a href='https://seekingalpha.com/symbol/CBDS' title='Cannabis Sativa, Inc.'>OTCQB:CBDS</a>, <a href='https://seekingalpha.com/symbol/BLOZF' title='Cannabix Technologies Inc.'>OTCPK:BLOZF</a>, <a href='https://seekingalpha.com/symbol/KSHB' title='KushCo Holdings, Inc.'>OTCQB:KSHB</a>, <a href='https://seekingalpha.com/symbol/MSRT' title='MassRoots, Inc.'>OTCQB:MSRT</a>, <a href='https://seekingalpha.com/symbol/SPRWF' title='Supreme Cannabis Co Inc.'>OTCQX:SPRWF</a>, <a href='https://seekingalpha.com/symbol/AGTK' title='Agritek Holdings, Inc.'>OTCPK:AGTK</a>, <a href='https://seekingalpha.com/symbol/AMMJ' title='American Cannabis Company, Inc.'>OTCPK:AMMJ</a>, <a href='https://seekingalpha.com/symbol/VAPE' title='Vape Holdings, Inc.'>OTCPK:VAPE</a>, HYYDF, <a href='https://seekingalpha.com/symbol/GBLX' title='GB Sciences, Inc.'>OTCQB:GBLX</a>, <a href='https://seekingalpha.com/symbol/AERO' title='Aero Grow International, Inc.'>OTCQB:AERO</a>, <a href='https://seekingalpha.com/symbol/MCOA' title='Marijuana Company of America, Inc.'>OTCQB:MCOA</a>, <a href='https://seekingalpha.com/symbol/HMLSF' title='Horizons Marijuana Life Sciences Index ETF'>OTC:HMLSF</a>, <a href='https://seekingalpha.com/symbol/CNAB' title='United Cannabis Corp.'>OTCQB:CNAB</a>, <a href='https://seekingalpha.com/symbol/FSPM' title='Fusion Pharm, Inc.'>OTC:FSPM</a>, <a href='https://seekingalpha.com/symbol/EAPH' title='Easton Pharmaceuticals, Inc.'>OTCPK:EAPH</a>, <a href='https://seekingalpha.com/symbol/SRNA' title='Surna Inc.'>OTCQB:SRNA</a>, <a href='https://seekingalpha.com/symbol/RMHB' title='Rocky Mountain High Brands, Inc.'>OTCQB:RMHB</a>, <a href='https://seekingalpha.com/symbol/PLPL' title='Plandai Biotechnology, Inc.'>OTCPK:PLPL</a>, <a href='https://seekingalpha.com/symbol/MNTR' title='Mentor Capital, Inc.'>OTCQX:MNTR</a>, <a href='https://seekingalpha.com/symbol/EDXC' title='ENDEXX Corp.'>OTCPK:EDXC</a>, <a href='https://seekingalpha.com/symbol/THCBF' title='THC Biomed International Ltd.'>OTCQX:THCBF</a>, <a href='https://seekingalpha.com/symbol/FSPM' title='Fusion Pharm, Inc.'>OTC:FSPM</a>, <a href='https://seekingalpha.com/symbol/EAPH' title='Easton Pharmaceuticals, Inc.'>OTCPK:EAPH</a>, <a href='https://seekingalpha.com/symbol/SRNA' title='Surna Inc.'>OTCQB:SRNA</a>, <a href='https://seekingalpha.com/symbol/RMHB' title='Rocky Mountain High Brands, Inc.'>OTCQB:RMHB</a>, <a href='https://seekingalpha.com/symbol/PLPL' title='Plandai Biotechnology, Inc.'>OTCPK:PLPL</a>, <a href='https://seekingalpha.com/symbol/MNTR' title='Mentor Capital, Inc.'>OTCQX:MNTR</a>, <a href='https://seekingalpha.com/symbol/EDXC' title='ENDEXX Corp.'>OTCPK:EDXC</a>, <a href='https://seekingalpha.com/symbol/THCBF' title='THC Biomed International Ltd.'>OTCQX:THCBF</a>, <a href='https://seekingalpha.com/symbol/KAYS' title='Kaya Holdings, Inc.'>OTCQB:KAYS</a>, <a href='https://seekingalpha.com/symbol/ENRT' title='Enertopia Corp'>OTCQB:ENRT</a>, <a href='https://seekingalpha.com/symbol/ENDO' title='Endocan CorporationA'>OTCPK:ENDO</a>, <a href='https://seekingalpha.com/symbol/NTRR' title='Neutra Corp.'>OTCQB:NTRR</a>, <a href='https://seekingalpha.com/symbol/REFG' title='Medical Cannabis Payment Solutions'>OTCPK:REFG</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415234\" data-linked=\"Pot stocks set to rally after Altria $1.8B investment in Cronos Group\" data-tweet=\"$CRON $CRON $CGC - Pot stocks set to rally after Altria $1.8B investment in Cronos Group https://seekingalpha.com/news/3415234-pot-stocks-set-to-rally-after-altria-1_8b-investment-in-cronos-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3415234-pot-stocks-set-to-rally-after-altria-1_8b-investment-in-cronos-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>104&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415233\" data-ts=\"1544184944\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRON\" target=\"_blank\">CRON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415233-altria-taking-1_8b-stake-in-cronos-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altria taking $1.8B stake in Cronos Group</a></h4><ul><li>Nasdaq has suspended trading in Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) pending the release of news.</li><li><strong>Update</strong>: Altria Group (NYSE:<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a>) has <a href=\"https://seekingalpha.com/pr/17351890-altria-make-growth-investment-cronos-group\" target=\"_blank\">agreed </a>to take a 45% stake in CRON via the purchase of stock at C$16.25 per share totaling ~C$2.4B (US$1.8B). MO will have the right to nominate four directors, including one independent, and will receive a warrant to acquire an additional 10% stake at C$19.00 per share.</li><li>Shares will resume trading at 7:45 am ET.</li><li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) and Tilray (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>) are upÂ <font color=\"green\">2%</font>Â andÂ <font color=\"green\">4%</font>, respectively, premarket.</li><li><strong>Update</strong>: CRON is upÂ <font color=\"green\">22%</font>Â premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415233\" data-linked=\"Altria taking $1.8B stake in Cronos Group\" data-tweet=\"$CRON $CRON $MO - Altria taking $1.8B stake in Cronos Group https://seekingalpha.com/news/3415233-altria-taking-1_8b-stake-in-cronos-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3415233-altria-taking-1_8b-stake-in-cronos-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>90&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415228\" data-ts=\"1544184263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMS\" target=\"_blank\">FMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415228-fresenius-down-10-premarket-on-softer-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fresenius down 10% premarket on softer guidance</a></h4><ul><li>Fresenius Medical Care (NYSE:<a href='https://seekingalpha.com/symbol/FMS' title='Fresenius Medical Care AG & Co. KGAA'>FMS</a>) is downÂ <font color=\"red\">10%</font>Â premarket on light volume following its <a href=\"https://www.reuters.com/article/us-usa-china-huawei-bolton/trump-aide-bolton-says-he-knew-in-advance-about-huawei-arrest-npr-reporter-idUSKBN1O5277\" target=\"_blank\">statement </a>that it does not believe its 2020 outlook is achievable considering its expectations for 2018 and 2019.</li><li>It now expects sales growth of mid-single digits and flat earnings next year compared to its previous forecast of 7.1 - 10.3% and 8.3 - 12.6%, respectively.</li><li>From 2020 onward, it now expects mid-single-digit sales growth and net income to grow slightly faster than sales.</li><li>Management attributes the softness to its dialysis business and clinic chain Helios.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415228\" data-linked=\"Fresenius down 10% premarket on softer guidance\" data-tweet=\"$FMS - Fresenius down 10% premarket on softer guidance https://seekingalpha.com/news/3415228-fresenius-down-10-premarket-on-softer-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3415228-fresenius-down-10-premarket-on-softer-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415221\" data-ts=\"1544183022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNA\" target=\"_blank\">MRNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415221-moderna-prices-upsized-ipo-trading-commences-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moderna prices upsized IPO, trading commences today</a></h4><ul> <li>Moderna (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNA' title='Moderna, Inc.'>MRNA</a>) <a href=\"https://seekingalpha.com/pr/17351772-moderna-announces-pricing-initial-public-offering\" target=\"_blank\">prices</a> its IPO of 26,275,993 shares of       common stock at a price of $23.00 per share, for the expected gross proceeds of $604.3M.</li><li>Underwriters over-allotment is additional 3,941,398       shares.</li><li>Closing date is December 11.</li><li>The IPO is upsized from the previous plan of 21,739,131 share offering.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3412682-moderna-sets-terms-ipo\" target=\"_blank\">Moderna sets terms of IPO</a> (Nov. 28)</li><li><strong>Update</strong>: Shares opened at $22.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3415221\" data-linked=\"Moderna prices upsized IPO, trading commences today\" data-tweet=\"$MRNA - Moderna prices upsized IPO, trading commences today https://seekingalpha.com/news/3415221-moderna-prices-upsized-ipo-trading-commences-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3415221-moderna-prices-upsized-ipo-trading-commences-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415220\" data-ts=\"1544182749\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTNT\" target=\"_blank\">QTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415220-quotient-prices-common-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quotient prices common stock offering</a></h4><ul> <li>Quotient (NASDAQ:<a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a>) <a href=\"https://seekingalpha.com/pr/17351782-quotient-limited-announces-pricing-underwritten-offering-ordinary-shares\" target=\"_blank\">prices</a> its previously announced public offering of 9,230,770 ordinary shares at a price of $6.50 per share, for net proceeds of ~$56.1M.</li><li>Underwriters over-allotment is an additional 1,384,615 ordinary shares.</li>   <li>Net proceeds will be used to fund the ongoing scale up and, if approved, commercialization of MosaiQ and for working capital and other general corporate purposes.</li><li>Closing date is December 11.</li><li>Shares are downÂ <font color=\"red\">6%</font>Â premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415119-quotient-limited-readies-stock-offering-shares-6-percent-hours\" target=\"_blank\">Quotient Limited readies stock offering; shares down 6% after hours</a> (Dec. 6)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3415220\" data-linked=\"Quotient prices common stock offering\" data-tweet=\"$QTNT - Quotient prices common stock offering https://seekingalpha.com/news/3415220-quotient-prices-common-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3415220-quotient-prices-common-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415218\" data-ts=\"1544182396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOS\" target=\"_blank\">SHOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415218-on-sears-hometown-and-outlet-stores-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Sears Hometown and Outlet Stores&#39; Q3 results</a></h4><ul><li>Sears Hometown and Outlet (NASDAQ:<a href='https://seekingalpha.com/symbol/SHOS' title='Sears Hometown and Outlet Stores, Inc.'>SHOS</a>) reports comparable-store sales decreased 0.2% in <a href=\"https://seekingalpha.com/pr/17351819-sears-hometown-outlet-stores-inc-reports-third-quarter-2018-results\" target=\"_blank\">Q3</a>.</li><li>Comp for Hometown fell 3.4% while Outlet grew 5.7%.</li><li>Segment sales: Hometown:$212.69M (-18.2%); Outlet sales: $126.42M (+0.3%).</li><li>Commercial sales increased 26.4%.</li><li>SearsHometown.comÂ sales were up 115% Y/Y.</li><li>Gross margin rate improved 250 bps to 25%.</li><li>SG&amp;A expense rate up 110 bps to 25.2%.</li><li>Merchandise inventories dropped 16.1% to $297.6M.</li><li>Store count -160 Y/Y to 761.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415200-sears-hometown-outlet-reports-q3-results\" target=\"_blank\">Sears Hometown and Outlet reports Q3 results</a> (Dec. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415218\" data-linked=\"More on Sears Hometown and Outlet Stores&#39; Q3 results\" data-tweet=\"$SHOS - More on Sears Hometown and Outlet Stores&#39; Q3 results https://seekingalpha.com/news/3415218-on-sears-hometown-and-outlet-stores-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3415218-on-sears-hometown-and-outlet-stores-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415217\" data-ts=\"1544182372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIVE\" target=\"_blank\">VIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415217-viveve-prices-common-stock-offering-shares-down-16-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viveve prices common stock offering; shares down 16% premarket</a></h4><ul> <li>Viveve Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a>) <a href=\"https://seekingalpha.com/pr/17351785-viveve-announces-pricing-public-offering-shares-common-stock\" target=\"_blank\">prices</a> its public offering of 13,333,334 shares of common stock at a price of $1.50 per share, for estimated gross proceeds of $20M.</li>   <li>Underwriters over-allotment is an additional 1,999,999 shares.</li><li>Net proceeds will be used to support the commercialization of products, to obtain additional regulatory clearances and to conduct the VIVEVE II Sexual Function and LIBERATE \u2013 International and LIBERATE \u2013 U.S. stress urinary incontinence (NYSE:<a href='https://seekingalpha.com/symbol/SUI' title='Sun Communities Inc.'>SUI</a>) clinical trials, and for general corporate and working capital purposes.</li><li>Closing date is December 11.</li><li>Shares are downÂ <font color=\"red\">16%</font>Â premarket.</li>        </ul><div class=\"tiny-share-widget\" data-id=\"3415217\" data-linked=\"Viveve prices common stock offering; shares down 16% premarket\" data-tweet=\"$VIVE $VIVE $SUI - Viveve prices common stock offering; shares down 16% premarket https://seekingalpha.com/news/3415217-viveve-prices-common-stock-offering-shares-down-16-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3415217-viveve-prices-common-stock-offering-shares-down-16-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415213\" data-ts=\"1544181737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIG\" target=\"_blank\">BIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415213-big-lotsminus-7_6-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BIG Lots -7.6% on earnings miss</a></h4><ul><li>Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>) reports comparable-store sales rose 3.4% in <a href=\"https://seekingalpha.com/pr/17351850-big-lots-reports-third-quarter-results\" target=\"_blank\">Q3</a>, meets guidance ofÂ +2% to +4%.</li><li>Gross margin rate down 10 bps to 39.9%.</li><li>SG&amp;A expense rate up 120 bps to 38%.</li><li>Inventory +3.5% Y/Y to $1.07B.</li><li><b>Q4 Guidanc</b>e:Â Comparable-store sales: flat to +2%;Â AdjustedÂ EPS: $2.20 to $2.40.</li><li><b>FY2018 Guidance</b>: Comparable-store sales: ~+1%; AdjustedÂ EPS:Â $3.55 to $3.75.</li><li>Bruce Thorn, President and Chief Executive Officer of Big Lots, stated, \"In terms of third quarter, we were pleased to achieve our second consecutive quarter of positive comps, but our bottom line results fell short of our expectations.Â  While we expect near-term results to be challenging this holiday season, we have a strong brand, great people, and we are working swiftly to enhance our current strategy, identify new growth opportunities, and position our business for profitable expansion well into the future.\"</li><li>BIGÂ <font color=\"red\">-7.6%</font>Â premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415207-big-lots-misses-0_16-beats-revenue\" target=\"_blank\">Big Lots misses by $0.16, beats on revenue</a> (Dec. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415213\" data-linked=\"BIG Lots -7.6% on earnings miss\" data-tweet=\"$BIG - BIG Lots -7.6% on earnings miss https://seekingalpha.com/news/3415213-big-lotsminus-7_6-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3415213-big-lotsminus-7_6-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":69,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}